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ABSTRACT
The homeobox transcription factor SIX1 contributes to both tumor development
and progression. Numerous studies have determined that the inappropriate expression of
embryonic genes, in particular transcription factors, contributes to carcinogenesis. SIX1
is essential for the development of numerous organs including the auditory and olfactory
system as well as the kidney, by promoting proliferation, survival and migration of
progenitor cells during embryogenesis. SIX1 has also been shown to increase cancer cell
proliferation, survival and invasion. The aberrant expression of SIX1 occurs in numerous
adult and pediatric cancers. We have previously determined that our in-vitro model
system for HPV16-mediated tumorigenesis shares many important features with cervical
cancer and enables us to study the molecular mechanisms of transformation and
immortalization in our cell human keratinocyte (HKc) lines. SIX1 mRNA and protein
levels are overexpressed in our HPV16-transformed HKc lines at the differentiationresistant stage (HKc/DR) compared with early passage, HPV16-immortalized HKc
(HKc/HPV16) and in HKc/HPV16 compared to normal HKc. Furthermore, we have
recently determined that SIX1 overexpression in HKc/HPV16 induces the differentiationresistant phenotype characteristic of HKc/DR, and that SIX1 overexpression in HKc/DR
induces tumorigenicity. In this study, we explored the role of SIX1 as a regulator of
growth and transformation in normal HKc, and its role in the maintenance of growth and
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a transformed phenotype in HKc/HPV16 and HKc/DR. We determined that loss of SIX1
is not tolerated by HKc/DR, which appear to be “addicted” to this oncogene. Decreased
SIX1 expression results in slower proliferation and decreased HPV16 E6/E7 mRNA
levels. We utilized Affymetrix GeneChip Arrays to explore the gene expression changes
associated with decreased SIX1 expression in HKc/DR. Ingenuity Pathway Analysis,
real-time PCR and functional cell-based assays determined that SIX1 is vital for cell
survival; the decline in SIX1 causes a transition from the mesenchymal phenotype
characteristic of HKc/DR towards the standard epithelial phenotype (mesenchymalepithelial transition, MET). MET is accompanied by a switch in TGF-β signaling from an
EMT-inducing tumor promoter to a tumor suppressor in HKc/DR cells. Additionally, we
observed that SIX1 overexpression in normal HKc extends their lifespan and induces
epithelial-mesenchymal transition, EMT. In summary, our studies suggest that SIX1 is
necessary for cell survival in HPV-16 –transformed cells and may potentially become a
suitable therapeutic target for HPV-driven cancers.
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CHAPTER 1
INTRODUCTION

1.1 SIX1 IN NORMAL AND HPV-16 TRANSFORMED HUMAN KERATINOCYTES
The retinal determination gene network (RDGN) was first discovered in
Drosophilia eye formation and, over the years, has become a model system for analyzing
the genetic and molecular mechanisms of cell fate determination. RDGN is composed of
dachshund (dac/ Dach), tyrosine phosphatase eyes absent (eya/ Eya) and the SIX family
sine oculis (so/ SIX) (Liu et. al., 2016). Genes from this network are highly conserved
during evolution and encode nuclear transcription factors and cofactors that regulate
morphogenesis in mammals. This network is aberrantly expressed in several pediatric and
adult cancers: Eya and SIX genes are known to be upregulated and Dach genes are shown
to be downregulated (Liu et. al., 2016).
SIX1 belongs to the SIX superfamily of homeobox genes, which encode
transcription factors. These proteins have an essential role in organogenesis and
tumorigenesis through the activation and inhibition of numerous downstream targets. The
SIX superfamily are homologous to Drosophilia sine oculis (so), optix and DSix4 family
of genes. The SIX family members in flies have homologs in many organisms within the
animal kingdom, including mammals. Analysis of the SIX gene set within vertebrates has
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shown that each of the SIX1 gene has two members of each subclass: Six 1/2 (sine oculis,
so), Six 3/6 (optix) and Six 4/5 (DSix4) (Kumar et. al., 2009).
The SIX family members are DNA-specific transcription factors that consist of
two evolutionarily conserved domains. DNA binding is elicited through the homeobox
nucleic acid recognition domain (HD), which are 60 amino acids in length. The SIX
domain (SD) is directly adjacent to HD, 146 amino acids in length and contributes to
protein-protein interactions (Kumar et. al., 2009). SIX1 is ubiquitously expressed in
humans and plays a critical role in the development of major organ systems including the
muscle, kidney, brain, auditory and olfactory. SIX1 utilizes cofactors, coactivators and
corepressors to regulate the transcription of downstream targets. In the absence of Eya,
Dach regulates SIX1 to suppress gene expression. On the other hand, Eya phosphatase
recruits coactivators to initiate transcription of target genes (Kumar et. al., 2009).
Numerous studies have highlighted the importance of SIX1/EYA in development
and disease, including cancer. For example, mutation of the SIX1 gene causes the human
disease brancchio-oto-renal (BOR) syndrome. Classified as a developmental disorder,
BOR syndrome is clinically characterized with hearing loss and malformations of the
kidney and/-or urinary tract. Specifically, researchers have observed one SD mutation as
well as two HD mutations that affect SIX1-EYA interaction and SIX1- DNA binding
(Ruf et. al., 2004) Overall, targeting this transcriptional complex will benefit patients in
the clinical setting.
SIX1 is a master regulator of development where it plays a role in normal
organogenesis. Numerous studies have identified that the inappropriate expression of
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embryonic genes in cancer, in particular transcription factors, contribute to
carcinogenesis (Abate-Shen et. al., 2002). Elevated SIX1 levels in malignant cells is
sufficient to increase cellular proliferation, survival and invasion, similar to what is
observed during embryonic development (Christensen et. al., 2008). In breast cancer cell
lines, gene amplification is a type of mechanism shown to increase SIX1 expression
(Reichenberger et. al., 2005). The aberrant expression of SIX1 occurs in numerous adult
human cancers, including breast, ovarian, cervical and hepatocellular carcinomas, and
pediatric malignancies including rhabdomyosarcoma and Wilms’ tumor (Coletta et. al.,
2010).
SIX1 overexpression has been shown to correlate with increased malignancy,
lymph node metastasis and poor survival in cancer patients (Coletta et. al., 2008;
Micalizzi et. al., 2009). For example, studies have established that the overexpression of
SIX1 in immortalized, non-tumorigenic mammary epithelial cells induces malignant
transformation, leading to highly aggressive and invasive tumors in nude mice. Studies
have demonstrated that SIX1 is overexpressed in half of primary mammary carcinomas
and most metastatic lesions (Coletta et. al., 2008). Along the same lines, SIX1
overexpression in human breast cancer cell lines induces epithelial-mesenchymal
transition (EMT), enhancing metastasis in-vitro and in-vivo (Coletta et. al., 2008;
Micalizzi et. al., 2009). SIX1 has also been shown to be overexpressed in cervical cancer
cell lines and tissues, which are correlated with increased malignancy and metastasis
(Tan et. al., 2011; Zheng et. al., 2010). SIX1-induced EMT is associated with Smaddependent transforming growth factor-beta (TGF-β) signaling and increased expression
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of TGF-β receptor type I (TβRI), allowing SIX1 to induce lymphangiogenesis and
metastasis by up-regulating VEGF-C, a lymphangiogenic factor (Wang et. al., 2012).

1.2 EPITHELIAL-MESENCHYMAL TRANSITION (EMT)
SIX1 overexpression is associated with tumor initiation, progression and
metastasis. Whole genome sequencing of tumor tissues implicate SIX1 in its ability to
decrease epithelial-related genes and increase mesenchymal-related genes and that SIX1induced tumors undergo EMT, primarily depending on the activation of TGF-β and p38MAPK (Xu H et. al., 2014; Xu H et. al., 2015). Through the interaction of SIX1 with
Wnt and mitogen-activated protein kinase (MAPK)/ERK signaling, tumors are able to
attain EMT and stem cell-like features (Xu H et. al., 2014).
Epithelial and mesenchymal cell phenotypes are established early in normal
development. However, these two cell phenotypes are highly dynamic and constantly in
motion, depending on the cell type and environment. The conversion between these cell
phenotypes, mechanistically labelled as Epithelial-Mesenchymal Transition (EMT) and
the reverse Mesenchymal-Epithelial Transition (MET), provides elasticity during
embryogenesis, wound healing and regeneration of differentiated tissues (Micalizzi et.
al., 2010). During developmental EMT, there are highly organized and well-defined
multi-step events that allow the transition of immotile, polarized and cuboidal epithelial
cells to gain a motile, apolar and fibroblastic phenotype. During carcinogenesis, epithelial
cells undergoing EMT acquire resistance to suspension-induced cell death (anoikis) with
the subsequent increase in cellular migration and invasion. This allows them to efficiently
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respond to extracellular signals, involving extracellular matrix (ECM) components and
soluble growth factors including transforming growth factor-beta (TGF-β) and epidermal
growth factor (EGF) (Lee et. al., 2012; Micalizzi et. al., 2010). The reverse holds true for
mesenchymal cells where they are able to begin MET (Figure 1.1) (Micalizzi et. al.,
2010).
Cancer-associated EMT has been observed in several malignancies including
breast, cervical and colon. EMT becomes exaggerated in malignant cells and is associated
with the downregulation of epithelial markers, such as E-cadherin, and the upregulation
of mesenchymal markers, such as N-cadherin and Vimentin- the major hallmarks in the
EMT cascade (Lee et. al., 2012; Micalizzi et. al., 2010). The metastatic spread of
malignant cells occurs in a multi-stepwise fashion, following EMT. Tumorigenic cells
leave their primary site, invade the basement membrane, intravasate into the local
lymphovascular, disseminate through the circulation, and extravasate into a secondary
site, thereby colonizing distant organs, depending on the cancer type, setting the stage for
metastasis (Figure 1.2) (Micalizzi et. al., 2010). Additionally, numerous regulators of
EMT have been misexpressed in cancers such as TGF-β, Wnt, Snail/Slug, Twist and
SIX1. Potentially, these and various other transcription factors appear to have a clinical
significance and have been recently identified to be prospective novel drug targets (Lee
et. al., 2012; Micalizzi et. al., 2010).
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Figure 1.1 Transition between epithelial and mesenchymal state of cells.

Figure 1.2 The metastatic spread of malignant cells facilitated through EMT.
Tumorigenic cells leave their primary site, invade the basement membrane, intravasate
into the local lymphovascular, disseminate through the circulation, and extravasate into a
secondary site, leading to metastasis. At the distant colonized organ, cells can revert to an
epithelial phenotype through MET.

6

1.3 TRANSFORMING GROWTH FACTOR-BETA (TGF-β)
Similar to many developmental signaling pathways misused in cancer, TGF-β
signaling is known to be connected to numerous pathologic processes and its function
during organogenesis parallels its role in neoplasia (Micalizzi et. al., 2009). TGF-β is an
ubiquitously expressed cytokine that contributes a dual role in tumor formationsuppressing tumor growth in normal cells and early neoplastic lesions, while promoting
invasive migration and metastasis in the later stages of carcinogenesis (Micalizzi et. al.,
2009; Xu H et. al., 2014; Xu H et. al., 2015). This soluble growth factor is heavily
involved in EMT and is a regulator of tumorigenesis. SIX1 has been shown to increase
TGF-β signaling; this signaling pathway is a critical contributor to cancer progression
and metastasis by inducing oncogenic EMT. SIX1 expression selectively promotes the
pro-tumorigenic activity of TGF-β while halting its growth-inhibitory functions
(Micalizzi et. al., 2009). TGF-β contains three isoforms: TGFβ1, TGFβ2 and TGFβ3; and
mediates signaling by binding to three receptors: TGF-β receptor type I (TβRI), type II
(TβRII) and type III (TβRIII) (Meulmeester et. al., 2011; Xu H et. al., 2014; Xu H et. al.,
2015).

1.4 HUMAN PAPILLOMAVIRUS (HPV) AND CERVICAL CANCER
Cervical cancer is the leading cause of cancer morbidity and second leading cause
of cancer mortality in women worldwide. There are about 500,000 new cases and
300,000 deaths annually due to cervical cancer (Peralta-Zaragoza et. al., 2012). Virtually
all cervical cancer cases are due to persistent infection with a high-risk human papilloma
virus (HPV). Infection with HPV is the most common sexually transmitted viral disease
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(STD). Currently, 79 million people in the USA have acquired an HPV infection. By the
age of 50, about 80% of women will have acquired an HPV infection (Society AC., 2013;
Peralta-Zaragoza et. al., 2012; Saslow et. al., 2012).
HPVs are small, non-enveloped viruses containing circular, double-stranded
DNA. HPV infects the epithelial cells of skin and mucosae. The HPV genome encodes
six to eight early and two late proteins. There are approximately 200 HPV types, 40 of
which can infect the genital mucosa (Faridi et. al., 2011). HPVs can be further classified
based on whether or not they lead to cervical cancer or benign genital warts: hence, we
distinguish high-risk (oncogenic) types- that cause virtually 99% of cervical cancer casesfrom low-risk (non-oncogenic) types that cause anogenital warts. Among the oncogenic
HPV types, HPV16 and 18 are the most common, causing about 70% of cervical cancers.
The non-oncogenic HPV types include HPV6 and 11, responsible for about 95% of
genital warts (Crow JM, 2012; Grainge et. al., 2005).
Most HPV infections are asymptomatic and spontaneously clear within 9-18
months, or (in some cases) the HPV remains latent at undetectable levels in the cervical
epithelium. However, approximately 10% of infected individuals cannot naturally clear a
high-risk HPV infection and are at risk for developing cervical cancer, which is known to
be a slow but progressive disease. Progression to cervical carcinogenesis first starts with
an infection to the genital mucosae of a high-risk HPV type. As the infection persists due
to a multitude of factors, this can progress through early and then late stages of dysplasiaCervical Intraepithelial Neoplasia I, II and III (CIN I, CIN II, CIN III) before developing
into invasive cervical carcinoma (Saslow et. al., 2012). Although new infections decrease
with age, risk of persistence is known to increase with age. Currently, there are two main
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methods known to prevent or detect persistent, high-risk HPV infection. Primary
prevention with a prophylactic Gardasil-9 vaccine can prevent infections by nine HPV
types: 6, 11, 16, 18, 31, 33, 45, 52 and 58 (Harper DM et. al., 2017). Secondary
prevention with the Papanicolaou (Pap) smear test can detect abnormal cytology of
infected cervical cells (Figure 1. 3) (Crow JM, 2012).

Vaccine

Pap smear

Figure 1.3 High-risk HPV infection and progression to invasive cervical carcinoma.
Cervical cells can clear an infection through the host immune system or potentially
progress. Persistors can progress to CIN I, which can potentially regress or progress to
CIN II/III. At the later stages of pre-malignancy, clinical regression is possible but
progression is probable. The main methods to prevent and/or detect an HPV infection
include a prophylactic Gardasil-9 vaccine or the Pap test.
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1.5 IN-VITRO MODEL SYSTEM OF HPV16-MEDIATED TRANSFORMATION OF
NORMAL HUMAN KERATINOCYTES (HKc)
Our laboratory has developed an in-vitro model system of HPV16-mediated
transformation of normal cells to explore the cellular and molecular events associated
with HPV infection. Primary or secondary cultures of human foreskin keratinocytes go
through a series of defined premalignant steps that represent the early and late stages of
cervical carcinogenesis. Normal human keratinocytes (HKc) were isolated from neonatal
foreskin tissue and transfected with pMHPV16d, which contains two copies of the
HPV16 DNA in a head-to-tail configuration, and selected with G418. This resulted in
immortalization of the transfected cells (HKc/HPV16), which represents the first
transformed stage in the in-vitro model. With continuous passaging of HKc/HPV16,
HPV16 sequences are amplified and integration into host chromosomes take place
(Pirisi et. al., 1987). Similar to normal HKc, these immortalized cells were cultured in
keratinocyte-serum free medium (KSFM), requiring both epidermal growth factor (EGF)
and bovine pituitary extract (BPE) for proliferation. In addition, normal HKc and
HKc/HPV16 cells are sensitive to differentiation triggered by serum and high calcium
levels. Nonetheless, HKc/HPV16 cells can be cultured in the absence of EGF and BPE.
This gives rise to growth factor independent HKc (HKc/GFI) cells. An additional
selection step was performed, where HKc/GFI were exposed to 5% fetal bovine serum
(FBS) and 1mM calcium chloride (Figure 1.4). In this step, cells that do not differentiate
in response to these two reagents are obtained and are consequently called differentiation
resistant cells (HKc/DR) (Pirisi et. al., 1987, 1988). This is the last stage of premalignant
transformation in our model system and these cells are not tumorigenic when injected
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into nude mice. In order to undergo malignant conversion, HKc/DR need to be
transfected with other transforming genes such as viral ras or herpes simplex virus type 2
(HSV2) DNA (DiPaolo et. al., 1989; DiPaolo et. al., 1990). We have repeatedly shown
that HKc/DR are completely resistant to the anti-proliferative effects of TGF-β, whereas
HKc/HPV16 and normal HKc are sensitive to the tumor inhibiting effects of TGF-β
(Creek et. al., 1995).
We have established this in-vitro system in order to investigate various stages of
malignant transformation. We utilized microarrays to identify genes whose altered
expression may lead to transformation in this multi-step, pre-malignant process of invitro progression. Among the gene expression profiles that we had identified and that
needed to be further studied was SIX1 (Wan F et. al., 2008). This particular gene was
shown to be altered during the early and later stages of our model system in comparison
to normal cells.

Figure 1.4 in-vitro model system of HPV16-mediated transformation of normal HKc.
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1.6 SUMMARY AND GOAL OF RESEARCH
SIX1 overexpression has been shown to increase cancer cell proliferation,
survival and invasion. The overexpression of SIX1 is associated with tumorigenesis and
metastasis with poorer overall survival (Christensen et. al., 2008). We have previously
determined that SIX1 mRNA and protein levels are overexpressed in our HPV16transformed HKc lines at the differentiation-resistant stage (HKc/DR) compared with
early passage, HPV16-immortalized HKc (HKc/HPV16) and in HKc/HPV16 compared
to normal HKc. Furthermore, we have recently determined that SIX1 overexpression in
HKc/HPV16 induces the differentiation-resistant phenotype characteristic of HKc/DR,
and that SIX1 overexpression in HKc/DR induces tumorigenicity. These findings
strongly suggest that SIX1 has a role in regulating the growth and transformation of
normal HKc, and that it plays an important role in the maintenance of growth and a
transformed phenotype in HKc/HPV16 and HKc/DR. In summary, our studies suggest
that SIX1 is necessary for cell survival in HPV-16 –transformed cells and may potentially
become a suitable therapeutic target for HPV-driven cancers.
The main goal of this study is to explore the role of SIX1 in HPV16-transformed
human keratinocytes by following the cellular and molecular changes associated with the
inhibition of SIX1 expression.
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CHAPTER 2
INHIBITION OF SIX1 EXPRESSION PRODUCES MESENCHYMALEPITHELIAL TRANSITION AND DECREASES E6/E7 EXPRESSION IN
HPV16-TRANSFORMED HUMAN KERATINOCTYES

2.1 INTRODUCTION
Cervical cancer is the leading cause of cancer morbidity and second leading cause
of cancer mortality in women worldwide. There are about 500,000 new cases and
300,000 deaths annually due to cervical cancer. Virtually all cervical cancer cases are due
to persistent infection with a high-risk human papilloma virus (HPV). Infection with
HPV is the most common sexually transmitted viral disease (STD). Currently, 79 million
people in the USA have an HPV infection. By the age of 50, about 80% of women will
have acquired an HPV infection (American Cancer Society; Peralta-Zaragoza et. al.,
2012; Saslow et. al., 2012).
HPVs are small, non-enveloped viruses containing circular, double-stranded
DNA. HPV infects the epithelial cells of skin and mucosae. The HPV genome encodes
six to eight early and two late proteins. There are approximately 200 HPV types, 40 of
which can infect the genital mucosa. HPVs can be further classified based on whether or
not they lead to cervical cancer or benign genital warts: hence, we distinguish high-risk
(oncogenic) types- that cause virtually 99% of cervical cancer cases- from low-risk (non-
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oncogenic) types that cause anogenital warts. Among the oncogenic HPV types, HPV16
and 18 are the most common, causing about 70% of cervical cancers. The non-oncogenic
HPV types include HPV6 and 11, responsible for about 95% of genital warts. Most HPV
infections are asymptomatic and are spontaneously cleared within 9-18 months, or (in
some cases) the HPV remains latent at undetectable levels in the cervical epithelium.
However, approximately 10% of infected individuals cannot naturally clear a high-risk
HPV infection and are at risk for developing cervical cancer. The Gardasil-9 vaccine can
prevent infections by nine HPV types: 6, 11, 16, 18, 31, 33, 45, 52 and 58 (Harper DM et.
al., 2017).
Numerous studies have determined that the inappropriate expression of
embryonic genes in cancer, in particular transcription factors, contribute to
carcinogenesis (Abate-Shen C et. al., 2002). Among the embryonic genes that also play a
role in cancer development, the sine oculis homeobox homolog 1 (SIX1) is essential for
the development of numerous organs including the auditory and olfactory system as well
as the kidney by promoting proliferation, survival and migration of progenitor cells
during embryogenesis. SIX1 has been shown to increase cancer cell proliferation,
survival and invasion, similar to what is observed during embryonic development
(Christensen et. al., 2008). In fact, many parallels exist between normal development and
tumorigenesis. The aberrant expression of SIX1 occurs in numerous adult human cancers,
including breast, ovarian, cervical and hepatocellular carcinomas as well as pediatric
malignancies including rhabdomyosarcoma and Wilms’ tumor (Coletta et. al., 2010).
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SIX1 overexpression has been shown to correlate with increased malignancy,
lymph node metastasis and poor survival in patients afflicted with cancer (Coletta et. al.,
2008; Micalizzi et. al., 2009). For example, SIX1 is overexpressed in half of primary
mammary carcinomas and most metastatic lesions (Coletta et. al., 2008). SIX1 has also
been shown to be overexpressed in cervical cancer cell lines and tissues, which are
correlated with increased malignancy and metastasis (Tan et. al., 2011; Zheng et. al.,
2010). Studies have established that the overexpression of SIX1 in immortalized and nontumorigenic mammary epithelial cells induces malignant transformation, leading to
highly aggressive and invasive tumors in nude mice. Moreover, SIX1 overexpression in
human breast cancer cell lines induces epithelial-mesenchymal transition (EMT),
enhancing metastasis in-vitro and in-vivo (Coletta et. al., 2008; Micalizzi et. al., 2009).
Nonetheless, very few studies have elicited the effects of the loss of SIX1, especially in
cervical carcinogenesis. Determining the role of SIX1 in the tumorigenesis and
progression of cervical cancer could facilitate diagnosis and treatment. This work would
contribute in our understanding of the deteriorative functions of SIX1 in cancers as a
global regulator of malignant transformation.
In order to study the cellular and molecular mechanisms of HPV-mediated
transformation, Pirisi et. al. established an in-vitro model system to study keratinocytes
progression toward the premalignant stages of cervical cancer. In brief, primary human
keratinocytes (HKc) were immortalized by transfection with pMHPV16d, which contains
a head-to-tail HPV16 DNA dimer, and selection with G418. These immortalized human
keratinocytes (HKc/HPV16) were selected in growth factor (epidermal growth factor and
bovine pituitary extract) free medium and became growth factor independent (HKc/GFI).
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A differentiation-resistant (HKc/DR) phenotype was then obtained by selection in serum
and calcium -supplemented medium. HKc/DR cells are not tumorigenic but can form
tumors in nude mice when these cells are transfected with activated Ras, Herpes Simplex
Virus 2 (HSV2) or the SIX1 oncogene (DiPaolo et. al., 1989; DiPaolo et. al., 1990).
Microarray studies conducted in our laboratory indicated that the in-vitro model
system reflects many cellular and molecular alterations characteristic of cervical cancer.
Therefore, our system for HPV16-mediated multi-step carcinogenesis shares important
features with cervical cancer and enables us to study the molecular mechanisms of
transformation and immortalization in our cell lines. It has been shown that SIX1 mRNA
and protein levels are overexpressed in all 4 cell lines (HKc/DR vs. HKc/HPV16), and
SIX1 mRNA and protein levels are consistently up-regulated during progression from
HKc/HPV16 to HKc/DR. SIX1 overexpression was also confirmed in about 25% of
cervical cancer tissue samples in a tissue array. Microarray results identified the
increased expression of SIX1 as a potential biomarker for cervical cancer (Wan F et. al.,
2008; Xu H et. al., 2014; Xu H et. al., 2015).
HPV16 is the most common among the high-risk oncogenic papillomaviruses that
contributes to cervical carcinogenesis (Zheng XH et. al., 2010; Zheng ZM et. al., 2011).
HPV16-mediated transformation requires the continuous expression of the viral
oncoproteins E6 and E7. These two oncogenes are necessary for malignant conversion
where E6 binds to and promotes the degradation of the p53 tumor suppressor protein; and
E7 binds to the Rb tumor suppressor protein thereby releasing the E2F transcription
factor. Consequently, this leads to tumor initiation, proliferation and genomic instability
(Ford HL et. al., 2000; Ganguly et. al., 2009; Li et. al., 2011).
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SIX1 overexpression in HKc/DR is associated to the increasing expression of
HPV16 E7 that marks premalignant progression of these cells. SIX1 is known to be
primarily under the control of E2F (Young AP et. al., 2003). When E7 binds to
unphosphorylated Rb, this tumor suppressor protein becomes inactivated and releases
E2F. The displacement of E2F from Rb allows E2F to activate the cell cycle and
promotes the aberrant expression of the embryonic gene SIX1 (Young AP et. al., 2003).
We have determined that SIX1 overexpression in early-stage HPV16immortalized human keratinocytes (HKc/HPV16) induces a differentiation-resistant
phenotype, and that SIX1 overexpression in differentiation-resistant HPV16-transformed
human keratinocytes (HKc/DR) induces tumorigenicity (Xu H et. al., 2014; Xu H et. al.,
2015). Furthermore, we have also shown that SIX1 modulates TGF-beta signaling by
decreasing canonical (Smad-mediated) responses and increasing non-canonical TGF-beta
signaling pathways in both HKc/HPV16 and HKc/DR (Xu H et. al., 2014; Xu H et. al.,
2015). We have also demonstrated that TGF-beta signaling through the Smads decreases
E6 and E7 expression, and that in turn, E7 decreases cells’ sensitivity to growth inhibition
by TGF-beta (Baldwin et. al., 2004). Therefore, it is reasonable to expect that a decrease
in SIX1 levels may be accompanied by a decrease in E6 and E7 expression, which would
in turn be reflected in the increase of p53 and Rb levels.
With this knowledge in mind, we studied the role of SIX1 as a regulator of growth
and transformation in HPV16-transformed human keratinocytes. Specifically, we studied
the functional consequences of suppressing SIX1 at late stages of HPV16-mediated
transformation of human keratinocytes by a variety of approaches. We could only obtain
partial (up to 80%) and transient knockdown of SIX1, as treatment with different anti-
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SIX1 sh- or siRNAs resulted in widespread cell death. The knockdown of SIX1 resulted
in slower proliferation rates and was associated with, decreased E6 and E7 mRNA and
increased p53 and Rb protein levels. We conclude that SIX1 expression is vital for cell
survival, particularly in our HKc/DR cell lines. The results of these studies will give us
valuable insight into the complex pathways affected through SIX1 and the functional
significance of its inappropriate expression and activity in cancers, particularly those due
to HPV.

2.2 MATERIALS AND METHODS
Cell culture and treatment
The cell lines discussed in this work, HKc/HPV16-d1, HKc/DRd-1 and
HKc/DRd-2, have been described previously (Pirisi et. al., 1987, 1988) In short, normal
HKc are isolated from neonatal foreskins and maintained in keratinocyte serum-free
medium supplemented with epidermal growth factor (EGF) and bovine pituitary extract
(BPE) (KSFM, Invitrogen, Carlsbad, CA). This medium will be referred as complete
medium. Normal HKc were transfected with a recombinant plasmid containing two
copies of the HPV16 DNA in a head to tail configuration. This gave rise to HPV16immortalized human keratinocytes, which are also cultured in KSFM. The immortalized
cells were then selected in medium devoid of EGF and BPE, giving rise to Growth Factor
Independent HKc (HKc/GFI). These cells were then further selected in basal KSFM
supplemented with 5% fetal bovine serum (FBS) and 1 mM calcium chloride to give rise
to differentiation resistant cell lines (HKc/DR). This medium will be referred as
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differentiation-resistant (DR) medium. HKc/DR were transfected with SIX1, giving rise
to HKc/DR-SIX1. These cells were also maintained in DR medium. All cells were
maintained in a humidified atmosphere of 5% CO2 at 37° C.
Plasmid constructs and stable transfection
Independently-derived HKc/DRd-1 and HKc/DRd-2 cell lines at 70% confluency
were transfected with a pSuper vector containing either a specific shRNA against human
SIX1, HuSH-29 shRNA based vector (Oligoengine, Seattle, WA) or a scrambled shRNA.
Additional plasmids utilized in this work include a pLXSN.neo vector expressing the
HPV16- E7 viral oncogene and the Harvey rat sarcoma virus (Hras)-V12 oncogene in the
pBABE.puro vector (Addgene, Cambridge, MA). Up to 5ug of the pLXSN.neo- E7 and
pBABe.puro- Hras-V12 vector were used for transfection. Moreover, three different
shRNA constructs against E7- that target three different positions within the HPV16 –E7
mRNA sequence, cloned in the backbone of the pSUPER.retro plasmid were used. 4ug or
5ug of anti-SIX1 shRNA construct and anti- E7 plasmid were used. Transfection
efficiency was monitored with the co-transfection of the pSUPER/puro plasmid (3:1
w/v), expressing GFP. As a vector control, the pSUPER/puro plasmid was used. Cells
were transfected with Lipofectamine 3000 (Invitrogen) following the manufacturer’s
instructions. Stable transfectants were selected with 3 ug/ml Puromycin (Toku-E,
Bellingham, WA).
RNA interference (RNAi)
HKc and HKc/DRd-1 cells were seeded in 6-well plates, grown to 70%
confluency and transfected with anti-SIX1 or anti-E7 siRNA or anti-GFP siRNA
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(control) duplexes using Lipofectamine RNAiMAX (Invitrogen) following the
manufacturer’s instructions. The following sequences were utilized in this study for
transfection with siRNAs targeting SIX1 and E7. SIX1-siR1: Forward 5’CCAGCUCAGAAGAGGAAUU, Reverse 5’-AAUUCCUCUUCUGAGCUGG;
SIX1-siR2: Forward 5’-CACGCCAGGAGCUCAAACU,
Reverse 5’-AGUUUGAGCUCCUGGCGUG; E7- siR1 (position 141):
Forward 5’-GGACAGAGCCCAUUACAAU, Reverse 5’AUUGUAAUGGGCUCUGUCC; E7- siR2 (position 653): Forward 5’GCUCAGAGGAGGAGGAUGA, Reverse 5’-UCAUCCUCCUCCUCUGAGC.
90 pmol siRNA was used per well and cells were incubated for 24, 48 and 72 hours
before being harvested for RNA and protein extraction, for real-time PCR and Enzymelinked immunosorbent assay analysis (ELISA), respectively.
Retroviral Infection
PA317 cells were transfected with four different shRNA constructs (Origene,
Rockville, MD) against SIX1 that target four different positions within the human SIX1
mRNA sequence. A pSuper vector containing a scrambled shRNA was used as a control.
Stable transfectants were selected with 3 ug/ml puromycin. After approximately 24
hours, virus-producing PA317 were cultured until sub confluent, fed fresh complete
medium and the medium was collected after 24 h and filter-sterilized (0.22 u pore size).
Virus stocks were aliquoted and stored at -80 °C. High passage HKc/Drd-1 cells
at 70% confluency were infected with control virus stock or anti-SIX1 shRNA virus in
KSFM containing polybrene (6 ug/ml). HKc/DRd-1 cells were maintained in DR medium
containing polybrene during the duration of the infection, approximately 24 hours. After

20

removal of virus-containing medium, the infected cells were re-plated and selected with
3 ug/ml puromycin.
Real-time PCR
Total RNA was isolated from cells using the RNeasy Plus Micro Kit (Qiagen,
Hilden, Germany). Reverse transcription was carried out with 1 μg of total RNA using
iScript cDNA Synthesis Kit (Bio-Rad, Hercules, CA). Real-time PCR was performed
using iQ SYBR Green Supermix (Bio-Rad). All procedures followed the manufacturer’s
instructions. The sequences of the primers used for real-time PCR are listed in Table 2.1.
GAPDH was used as an internal control. All samples were assayed in duplicates.

Table 2.1 Primer sequences used in Real-time PCR. Primer sequence 5’-3’.
Genes

Forward

Reverse

human β-catenin/
CTNNβ1
human CTGF

TTG AAA ATC CAG CGT GGA
CA
TTA CCA ATG ACA ACG CCT
CCT
TGC TCT TGC TGT TTC TTC GG

TCG AGT CAT TGC ATA CTG TC

GGC CTA AGA TCC CGT CCA
TC
GAT AGT TGT GAT CGC CTC
ACC
ACC AAC CTA CGG ATG ACT
CG
GGG AAG GTG AAG GTC GGA
GTC AA
CTGTCAAGGGCAGTAACCTGT
TGA GCC GCA TTC TGA ACG
AG
AATGTGGAGATGGACGCAG
CTT CCG AAC CAA GTT TGA
GAC

GTA AGA GGC TCC ACA AGC
TCC
GTC CTC TGA GTC GAA GCT
GTC
GCT CAT CAT CTG GCC ATT TT

human Ecadherin
human EGFR
human ETS1
human
Fibronectin
human GAPDH
human GUSB
human keratin 14
human keratin 15
human keratin 19
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CTT TTT GCC CTT CTT AAT GTT
CT
TGC CCC ATT CGT TCA AGT AG

TCT CAG CCT TGA CGG TGC
CAT
AGATAGGCAGGGCGTTCGT
GAT GAC TGC GAT CCA GAG
GA
TGGATCATTTCTGTGTTGGAGG
AGC GTA CTG ATT TCC TCC TC

human ki-67

ACG CCT GGT TAC TAT CAA
AAG G

CAG ACC CAT TTA CTT GTG
TTG GA

human MMP1

AAA ATT ACA CGC CAG ATT
TGC C
AGT CCA CCC TTG TGC TCT
TCC C
ACA GTG GCC ACC TAC AAA
GG
ATG ACA AGC GGT TTT ATC
CA
CGTGTGGAGTATTTGGATGAC
GCC CTT TGG TGA CTT TAT
GGA
GCC CAG CAC TTC ACG CAT
CAG
CAA ACT TGG AGT TCG CTT
GT
ATT CTC ACC TCC CCA AAG TC
ACC CCA CAT CCT TCT CAC TG

GGT GTG ACA TTA CTC CAG
AGT TG
TCT GCC ACC CGA GTG TAA
CCA T
CCG AGA TGG GGT TGA TAA TG

human MMP9
human Ncadherin
human Occludin
human p53
human PPARγ
human PTGS2
human Rb
human SIX1
human SNAIL
human TβRI
human TβRII
human TWIST
human Vimentin
HPV16- E6
HPV16- E7

CTT AAT TCC TCG AGA TAG
GC
GGT TCC TGT GTG CCC TTA TT
GTC CGC AGT CTT ACG AGG
AG
GAG AAC TTT GCC GTT GAA
GC
CAC AGT TAT GCA CAG AGC
TGC
CCG GAC AGA GCC CAT TAC
AAT

CTC CAG CTC ATC ACA GGA CT
AGTCTTCCAGTGTGATGATGG
GCA GCA GGT TGT CTT GGA TG
AGA CCA GGC ACC AGA CCA
AAG ACC
TTC AGA ATC CAT GGG AAA GA
ACT TAG GAC CCC AAG TCC AC
TAC AAA AAC CCA CGC AGA
CA
GTG AGA TGC AGA CGA AGC
TGC AAC CCA TGA AGG TAA
AA
GCT TGA GGG TCT GAA TCT
TGC T
TCC AGC AGC TTC CTG TAG GT
CAT ATA TTC ATG CAA TGT
AGG TGT A
ACG TGT GTG CTT TGT ACG
CAC

Enzyme-linked immunosorbent assay (ELISA)
Protein was isolated from cells using the Cell Lysis Buffer from the PathScan
Total p53 Sandwich ELISA kit (Cell Signaling, Danvers, MA). SigmaFAST Protease
Inhibitor (Sigma, Saint Louis, MO) was added to the resulting supernatant. PathScan
Total Rb Sandwich ELISA kit was then utilized according to the manufacturer’s
instructions. 50 ug of protein/sample was loaded into the p53 pre-coated wells. 150 ug of
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protein/sample was loaded into the Rb pre-coated wells. All samples were assayed in
replicates of two or three. Absorbance was read at 450 nm within 30 minutes using a
microplate reader.
Cell proliferation assay
To compare the growth rates of either HKc/DRd-1- SIX1sh or HKc/Drd-2SIX1sh and HKc/DRd-1-SCRAMsh or HKc/DRd-2-SCRAMsh, and HKc/HPV16d-1 the
WST-8 dye reagent from the Cell Counting Kit-8 (CCK8) sensitive colorimetric assay
was utilized (Dojindo, Rockville, MD). Proliferation was determined at 24-hour intervals.
5,000 cells were plated per well in 24-well plates in their respective media (1ml/well).
Cells were plated in triplicate wells and at the appropriate times, 50 ul of WST-8 dye
solution was added to each well and the plates were placed in a CO2 incubator for
2 hours. Absorbance was read at 450 nm with a microplate reader.
Gene-expression microarray analysis and validation by SYBR green real-time PCR
Total RNA from HKc/DR-SIX1-siRNA1, HKc/DR-SIX1-siRNA2 and HKc/DRcontrol-siRNA was isolated using Qiagen’s RNeasy Plus Micro Kit according to the
manufacturer’s protocol. RNA quality was assessed using an Agilent 2100 Bioanalyzer
and RNA Integrity Numbers ranged from 9.5 to 10.0. Microarray experiments were
performed using the Affymetrix GeneChip Human Gene 2.0 ST Arrays as we have
previously described (Xu H et. al., 2014).
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Statistical Analysis
Results were expressed as the mean ± standard deviation (SD). Data were
interpreted using student’s t-test. P ≤ 0.05, P ≤ 0.01 or P ≤ 0.001 were considered
statistically significant and indicated in the figures by *, ** or ***, respectively.

2.3 RESULTS
2.3.1 THE KNOCKDOWN OF SIX1 AFFECTS CELL VIABILITY IN HKc/DR
We utilized shRNA constructs targeting the human SIX1 gene to explore the
effects of suppressing this oncogene in HPV16-transformed human keratinocytes. AntiSIX1-shRNA-encoding sequences and a control, scrambled shRNA were cloned in the
pSuper-retro plasmid backbone (Oligoengine) and the resulting plasmids transfected into
two HKc/DR cell lines, HKc/DRd-1 and HKc/DRd-2 (Pirisi et. al., 1987). Transfected
cells were briefly selected with puromycin until vector controls died (approx. 72 h). Cells
were then collected for RNA extraction and plated for a growth curve (Figure 2.1, A).
The shRNA decreased SIX1 mRNA levels to about 20% of control (maximum) (Figure
2.1, B) and cells transfected with the anti-SIX1 shRNA exhibited much slower growth
than their controls, although after 96h in culture, recovery could already be observed in
one of the transfected lines (Figure 2.1, A). Further cultivation of these cells resulted in
SIX1 mRNA levels returning to 100% of control and proliferation rates recovering
completely (data not shown). Upon visual inspection, phase contrast photographs taken
of cells co-transfected with pSuper-retro-scrambled or pSuper-retro-SIX1-shRNA and
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GFP, at various times after transfection, demonstrated that loss of SIX1 leads to cell
death in HKc/DR (Figure 2.1 D, E).

A

B

C

E

D
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Figure 2.1 Loss of SIX1 in HKc/DR affects proliferation and HPV16- E6/E7 mRNA
expression levels. (A) The rate of proliferation decreases in HKc/DRd-1 and HKc/DRd-2
transfected with SIX1-shRNA plasmid. Cell proliferation at 24-hour intervals was
determined utilizing the WST-8 dye reagent from the Cell Counting Kit-8 (CCK8)
sensitive colorimetric assay. (B) The mRNA expression levels of SIX1, E6 and E7
decrease in HKc/HPV16 and HKc/DR transfected with a plasmid encoding anti-SIX1shRNA. Real-time PCR analysis for SIX1, E6 and E7 mRNA in HKc/DRd-1 and
HKc/DRd-2 cell lines. Levels of expression were normalized to GAPDH. (C) The protein
expression level of p53 increases while levels of Rb decrease in HKc/DRd-1 cell line
transfected with SIX1-shRNA plasmid. ELISA for p53 and Rb in HKc/DRd-1 transfected
with either control (anti-scram shRNA) or anti-SIX1 shRNA at indicated plasmid
concentrations. (D, E) Loss of SIX1 affects cell viability in HKc/DRd-1. Fluorescent and
phase-contrast images depicting transfection efficiency and morphology, respectively, of
HKc/DRd-1 cells 48 hours (top) and 4 days (bottom) post-transfection with anti-SIX1
shRNA plasmid. (E) Fluorescent and phase-contrast images depicting transfection
efficiency and morphology, respectively, of HKc/DRd-1 cells 48 hours (top) and 4 days
(bottom) post-transfection with control-shRNA and scrambled-shRNA plasmids. Images
are shown at 200X magnification.
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Figure 2.2 HKc/DR infected with four different shRNA constructs targeting human SIX1
gene. mRNA and protein expression levels of SIX1, E6 and E7 in HKc/DRd-1 cells
infected with four different shRNA constructs targeting four different positions within the
human SIX1 mRNA sequence. (A) Real-time PCR analysis of SIX1, E6 and E7 mRNA
in HKc/DRd-1 cell lines. Levels of expression were normalized to GAPDH. (B) ELISA
for p53 and Rb in HKc/DRd-1 infected with either control (anti-scram shRNA) or the
indicated anti-SIX1 shRNA constructs.

To fully understand the necessity of SIX1 in these differentiation resistant cell
lines, HKc/DRd-1 cells were infected with anti-SIX1 shRNA PA317 conditioned
medium. SIX1 loss was observed in cells treated with all four different constructs with
concomitant E6 and E7 loss in three of the shRNA constructs (Figure 2.2, A). Similarly,
in regards to p53 and Rb levels, we observed slight increases in protein levels (Figure 2.2,
B). Overall, these results indicate that SIX1 expression is vital for cell survival in the
late-stage HPV16 transformed human keratinocytes.

2.3.2 LOSS OF SIX1 CAUSES DECREASES OF HPV16 E6/E7 mRNA LEVELS IN
HKc/DR
The experiments described above also provided a first hint that SIX1 expression
may affect HPV16 E6/E7 mRNA expression. We have demonstrated that SIX1
knockdown in HKc/DRd-1 results in the decrease of HPV16- E6/E7 mRNA levels with a
simultaneous increase in p53 and decrease in Rb protein expression levels (Figure 2.1 B,
C). Therefore, we set out to further investigate this possibility through transient
transfections with pre-formed anti-SIX1 siRNA. We utilized two different siRNA
duplexes targeting different regions of the human SIX1 gene. In HKc/DRd-1 cells, SIX1
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mRNA levels decreased significantly, under these transient transfection conditions, at 24,
48 and 72 hours (Figure 2.3, A). Decreased SIX1 expression was associated with
decreases in HPV16-E6 and E7 mRNA levels (Figure 2.3 B, C). Consistent with a
decrease of active E6 levels, p53 protein levels increased significantly, with the greatest
rise observed 24 hours after SIX1 expression (Figure 2.3, D). Not surprisingly, p53
mRNA levels (which are high in HPV16-transformed cells) markedly decreased in
HKc/DR transfected cells with either of the two anti-SIX1 siRNA constructs (Figure 2.3,
E). Rb protein and mRNA levels followed similar trends, however to a lesser extent
(Figure 2.3 F, G).
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Figure 2.3 Loss of SIX1 with pre-formed anti-SIX1 siRNAs causes decreases of
HPV16- E6/E7 mRNA levels in HKc/DR. (A) (B) (C) Real-time PCR analysis for SIX1,
E6 and E7 mRNA in HKc/DRd-1 under transient transfection conditions at the indicated
time points. Levels of expression were normalized to GAPDH. (D) (F) Relative protein
expression of p53 and Rb, respectively, after transfection with pre-formed anti-SIX1
siRNAs in HKc/DRd-1 cells. p53 and Rb protein expression was detected by ELISA in
HKc/DRd-1 at indicated 24-hour interval time points. (E) (G) Relative mRNA expression
of p53 and Rb, respectively, in the HKc/DRd-1 cell line transfected with pre-formed antiSIX1 siRNAs. p53 and Rb mRNA were quantified by RT/PCR in HKc/DRd-1 at the
indicated 24-hour interval time points. Levels of expression were normalized to GAPDH.

Taken together, our data indicate that a loss of SIX1 expression in HKc/DR cells
is associated with decreased expression of the viral oncogenes E6 and E7. The
mechanisms in which SIX1 directly, or perhaps indirectly, affect E6 and E7 still need to
be elucidated.
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2.3.3 KNOCKDOWN OF E7 RESULTS IN DECREASED mRNA LEVELS FOR SIX1
Previous unpublished work in our laboratory determined that SIX1 levels could
be increased dramatically in normal HKc by the expression of HPV-16 E7, and by
siRNA-mediated inhibition of Rb expression, provided that p53 levels were reduced as
well by shRNA (Figure 2.4 A, B). We have also overexpressed HPV16 -E7 in HKc/DR
cells. Increased E7 expression resulted in the subsequent increase of SIX1 and HPV16E6 mRNA (Figure 2.5, A). Concomitantly, Rb and p53 protein levels, respectively, were
downregulated (Figure 2.5 B-E).
To better pinpoint the functional consequence of E7 suppression in HKc/DR cells,
the HKc/DRd-1 cell line was transiently transfected with two different siRNA duplexes
targeting HPV16 -E7. Cells were then collected for RNA and protein extraction 48 hours
after transfection. Both siRNAs produced a significant decrease in both E6 and E7
mRNA levels, up to 70% inhibition (Figure 2.6, A) accompanied by approximately 50%
decrease in SIX1 mRNA levels (Figure 2.6, B). These changes in E6, E7 and SIX1
mRNA levels were also associated with the expected changes in p53 and Rb mRNA and
protein levels (Figure 2.6 C-F).
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Figure 2.4 Increased SIX1 RNA expression in normal HKc and HKc/E7-expressing cells.
(A) Real-time PCR analysis of SIX1 mRNA in normal HKc expressing HPV16E7. SIX1
mRNA expression was normalized to GAPDH; (B) Real-time PCR analysis for SIX1 and
Rb mRNA in normal HKc co-transfected with a p53-shRNA plasmid and an anti-Rb
siRNA duplex. Levels of expression were normalized to GUSB.
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Figure 2.5 Increased SIX1 and HPV16- E6 mRNA expression in HKc/DR overexpressing
HPV16 E7 from the pLXSN.neo- E7 vector. (A) Real-time PCR analysis for SIX1 and
E6 mRNA in HKc/DR expressing HPV16 E7. Levels of expression were normalized to
GAPDH. (B) (D) Real-time PCR analysis of Rb and p53 mRNA in HKc/DR
overexpressing HPV16- E7. Levels of expression were normalized to GAPDH. (C) (E)
ELISA for Rb and p53 protein expression in HKc/DR overexpressing HPV16- E7 with
the use of pLXSN.neo- E7 vector.
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Figure 2.6 Knockdown of HPV16-E7 with pre-formed anti-E7 siRNAs results in
decreased mRNA levels of HPV16-E6 and SIX1. (A) (B) Real-time PCR analysis for E6,
E7 and SIX1 mRNA in HKc/DRd-1 under transient transfection conditions at 48 hours.
Levels of expression were normalized to GAPDH. (C) Real-time PCR analysis for p53
mRNA in HKc/DRd-1 48 hours after transient transfection. p53 expression was
normalized to GAPDH. (D) (F) ELISA for p53 and Rb protein expression in HKc/DRd-1
48 hours after transient transfection. (E) Real-time PCR analysis of p53 mRNA in
HKc/DRd-1 at 48 hours. Rb expression was normalized to GAPDH.

Collectively, these data suggest that a loss of E6/E7 expression is associated with
a decrease in the mRNA levels of SIX1. We tentatively explain these changes with the
interrelated effects of E7 and SIX1 on TGF-β signaling, as detailed in the Discussion.
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2.3.4 SIX1 KNOCKDOWN IN HKc/DR PROMOTES MESENCHYMAL-EPITHELIAL
TRANSITION (MET) AND RESETS THE LEVELS OF TGF-Β RECEPTORS 1 AND 2
We set out to investigate global gene expression during transient SIX1
knockdown in HKc/DRd-1 cells on Affymetrix GeneChip Human Gene 2.0 ST Arrays.
Direct, paired comparisons of gene expression were made among four individual clones
of HKc/DR-SIX1-siRNA1and HKc/DR-control-siRNA, and between HKc/DR-SIX1siRNA2 and HKc/DR-control-siRNA. We used Transcriptome Analysis Console (TAC)
software from Affymetrix to analyze the microarray results. To determine the
differentially expressed genes in the pairwise comparisons, we used a fold change >1.4
(up and down) and a P value ˂ 0.01 as cutoff values. In addition, Ingenuity Pathway
Analysis (IPA) was performed on the differentially expressed genes. Pairwise
comparisons identified 2447 differentially expressed genes after treatment with SIX1siRNA1: 794 genes were upregulated and 1653 genes were downregulated.
Correspondingly, 2693 differentially expressed genes were identified after treatment with
SIX1-siRNA2: 1580 genes were upregulated and 1113 genes were downregulated. We
then manually identified common genes between the two siRNA duplexes that were
associated with a transition towards an epithelial phenotype. We were interested in nine
genes that were downregulated and four genes that were upregulated through siRNA
treatment in HKc/DRd-1 cells (Tables 2.2, 2.3).
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Table 2.2 Expression of EMT-associated genes targeted by SIX1 and TGF-β in HKc/DR.
Decrease in target gene expression during transient SIX1 knockdown in HKc/DRd-1 cell
lines.

Table 2.3 Expression of MET-associated genes targeted by SIX1 and TGF-β in HKc/DR.
Increase in target gene expression during transient SIX1 knockdown in HKc/DRd-1 cell
lines.
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Unsupervised cluster analysis clearly differentiated the SIX1 knockdown cells
from controls and allowed for the identification of a cluster of genes that best separate the
two (Figure 2.7 A, B). IPA pathway analysis showed that the pathways most heavily
affected by decreased SIX1 expression were consistent with MET (Figure 2.7, C).
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Figure 2.7 Gene expression profiles of SIX1 knockdown in HKc/DR involve TGF-β
signaling, MET and apoptosis. (A) Unsupervised hierarchical clustering of differentially
expressed genes between HKc/DR control siR (left) and HKc/DR SIX1-siR2 (right). The
color represents the expression level of a gene above (red), below (green), or at neutral
(black) the mean expression level of that gene across all samples. Pairwise comparisons
identified 2693 differentially expressed genes after treatment with SIX1-siRNA2: 1580
genes were upregulated and 1113 genes were downregulated. (B) Heatmap depicting
select genes relevant to MET. (C) Illustration of downstream functional effects of gene
transcripts that are upregulated and downregulated. Canonical pathways and diseases &
functions that are differentially expressed as a result of SIX1 loss in HKc/DR (1.4 fold
change up and down; p-value ˂ .01). Ingenuity Pathway Analysis (IPA) indicates
deregulation of pathways related to invasion, proliferation, migration and apoptosis.

Among the many changes within these pathways, we observed a reduction in the
expression of the mesenchymal-related gene Vimentin (VIM) and an increase in the
expression of the epithelial-related genes Keratin 15 (K15) and Occludin (OCLN).
Furthermore, there was an increase in expression of the inflammatory response gene
prostaglandin-endoperoxide synthase 2, PTGS2 (cyclooxygenase-2, COX-2). There was
a decrease in the expression of the cell-cell adhesion complex molecule, β-catenin
(CTNNβ1) (Gumbiner et. al., 2005). We noted a decrease in the pro-survival factor
epidermal growth factor receptor (EGFR) and its associated ligand, transforming growth
factor alpha (TGF-α). There was a decrease in the angiogenic matricellular marker
connective tissue growth factor (CTGF/CCN2) and its downstream signaling effector
ETS proto-oncogene 1, transcription factor (ETS1) (Geisinger et. al., 2012; Ubink et. al.,
2016). mRNA levels for the markers for invasiveness, matrix metalloproteinase 1 and 9
(MMP1, MMP9), were also decreased. Lastly, there was a decrease in peroxisome
proliferator activated receptor gamma (PPARƴ), a ubiquitously expressed gene known to
regulate differentiation and cell growth (Sarraf et. al., 1999). These microarray data
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suggest that mesenchymal to epithelial transition is a functional consequence of SIX1
loss in the late-stages of HPV16-transformed human keratinocytes.
To validate data from the array analysis we performed real-time PCR on
HKc/DRd-1 cells treated with SIX1-siRNA2 48 hours after transfection. The mRNA
levels of K15 and OCLN both increased approximately 2.2-fold while VIM mRNA
levels decreased approximately 20%. Additionally, there was a significant increase, up
to 40%, in PTGS2/COX-2. These cells might be experiencing cell stress as a result of
SIX1 loss; and therefore, they react by increasing levels of inflammatory-response
genes. While the array data showed a 1.54-fold decrease in β-catenin expression, realtime PCR results revealed a 3-fold increase in mRNA levels. The shift away from a
mesenchymal phenotype can be associated with changes that follow a gain in cell-cell
adherens junctions typically seen in normal epithelial cells and β-catenin is a wellknown epithelial marker. There was a 40% decrease in EGFR mRNA levels following
transfection. Additionally, there was a 55% and 40% decrease in CTGF/CCN2 and
ETS1 mRNA levels, respectively. Tumorigenic cells are known to metastasize via blood
or lymphatic vessels through an increase in the mesenchymal-associated gene
CTGF/CCN2 (Ubink et. al., 2016). In addition, there was a 70% and 40% decrease in
MMP1 and MMP9 mRNA levels, respectively. Malignant cells can damage the
basement membrane thru the increase of proteolytic enzymes such as MMP1 and
MMP9. Lastly, there was a significant decrease in the proliferation and differentiation
marker PPARƴ. Therefore, a significant decrease of these EMT-inducing proteins is an
indication of the functional consequences brought on by a deficit in SIX1 (Figure 2.8).
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Figure 2.8 SIX1 knockdown induces markers of MET in HKc/DR. Levels of mRNA
expression of CTGF, CTNNβ1, EGFR, ETS1, K15, MMP1 and 9, OCLN, PPARγ,
PTGS2 and VIM were determined by real-time PCR analysis in HKc/DR control siR and
HKc/DR SIX1-siR2. Data were normalized to GAPDH expression.

Last, but not least, microarray data revealed a 1.57-fold increase in TβRI and a
1.84-fold decrease in TβRII. Real-time PCR confirmed these changes. We analyzed our
array data to locate gene expression changes that are regulated by TGF-β signaling
(Figure 2.9). We also identified increases in K15 (1.72 fold) and OCLN (2.11 fold) and
decreases in Hic1 (1.4), VIM (2.05), CTGF (1.72) and PLAT (3) in response to loss of
SIX1 and the differential expression of TGF-β receptors.
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Figure 2.9 SIX1 knockdown in HKc/DR resets the levels of TGF-β receptors 1 and 2.
Levels of mRNA expression of TGFβRI and TGFβRII were determined by Real-time
PCR analysis in HKc/DR control siR and HKc/DR SIX1-siR2. Data were normalized to
GAPDH expression.

2.4 DISCUSSION
The results shown above, taken together with our prior observation on the role of
SIX1 in HPV16-mediated transformation, point to the fact that SIX1 expression is
necessary for growth and survival of differentiation-resistant, HPV16-transformed
human keratinocytes (HKc/DR) and that these cells do not tolerate a decrease in SIX1
levels. Given the fact that SIX1 is virtually not expressed in normal adult cells, this gene
may become a suitable therapeutic target for HPV-driven cancers.
Deregulation of homeobox genes in cancer results in an out of context activation
of their development-restricted functions. There have been countless studies identifying
the link between normal organogenesis and neoplasia. Indeed, they both share many
pathways and basic molecular processes between them, demonstrating undoubtedly that
tumorigenesis and progression is an aberrant form of morphogenesis. The oncoprotein
SIX1 has an important role in the expansion of progenitor cell populations during
embryogenesis and is essential for the development of numerous organs. This
transcription factor has been shown to be aberrantly misexpressed in various pediatric
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and adult cancers. SIX1-induced EMT through TGF-β signaling enhances tumor
progression, invasion and metastasis in several malignancies.
Our previous work demonstrated that SIX1 mRNA and protein levels are
overexpressed in the in-vitro model system, and SIX1 mRNA and protein levels are
consistently up-regulated during progression from HKc/HPV16 to HKc/DR. We further
show that SIX1 overexpression in HKc/HPV16 induces a differentiation-resistant
phenotype, and that SIX1 overexpression in HKc/DR induces tumorigenicity. In the
current study, we focused on the role of SIX1 as a regulator of growth and
transformation in HPV16-transformed human keratinocytes. We studied the functional
consequences of suppressing SIX1 in the late stages of HPV16-transformed human
keratinocytes.
In our studies, we utilized shRNA technology to suppress SIX1 expression levels
in HKc/DR cells, resulting in decreased proliferation and widespread cell death.
Interestingly, in select transfections, we also detected significant increase in SIX1
expression levels in comparison to the HKc/DR scrambled shRNA control population.
However, stable transfections resulted in only transient decreases in SIX1
expression and inconsistent results, which we attributed to the impression that cell
populations were rapidly taken over by cells in which SIX1 was still being expressed.
Therefore, we decided to explore the effects of SIX1 inhibition in transient transfection
conditions, with pre-formed siRNA.
Previous studies have demonstrated that the transient inhibition of SIX1 in the
pancreatic cancer cell line, PANC-1, efficiently results in an 86% decrease of SIX1
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mRNA (Lerbs et. al., 2017). We utilized two siRNA duplexes targeting the human SIX1
gene and in doing so, we significantly reduced the mRNA expressions of SIX1, E6 and
E7 at all three time points tested. There was an initial significant decrease in p53 mRNA
levels; p53 protein levels increased as a result of SIX1 and E6 loss. Moreover, Rb
mRNA levels were considerably low at the various time points; however, there were
increases in Rb protein levels after the suppression of SIX1 and E7 mRNA expression.
Therefore, with the brief reduction of SIX1 expression, we were able to drastically
reduce E6 and E7 mRNA levels with the corresponding increases in p53 and Rb protein
levels. Thus, HPV oncoprotein expression in our cell lines could be modulated by SIX1.
These results also implied that SIX1 is able to promote malignant transformation and
growth of infected cervical cells together with the concomitant expression of HPV16-E6
and E7 (Liu D. et. al., 2014).
It has been reported that HPV-E7 plays a role in inducing the expression of SIX1.
HPV-negative C33a cells have very low SIX1 expression levels but the overexpression
of E7, not E6, has been shown to induce the expression of SIX1 (Liu D. et. al., 2014).
The data described in this paper on the reciprocal regulation of SIX1 and E6/E7 levels
suggest that SIX1 expression in our cell lines is modulated by HPV oncoproteins,
specifically HPV16 -E7. These results also imply that E7 relies on SIX1 to continuously
promote malignant transformation and tumor progression by upregulating SIX1
expression.
Similar to many developmental signaling pathways dysregulated in cancer, TGFβ signaling is known to be connected to numerous pathologic processes and its function
during ontogenesis parallels its role in neoplasia (Micalizzi et. al., 2009). TGF-β plays a
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dual role in tumor formation and is known to be associated with tumorigenesis,
including the progression of premalignant cervical lesions to invasive cervical cancer
(Baritaki et. al., 2007). TGF-β is a potent suppressor of tumor growth in normal cells and
early neoplastic lesions; however, this cytokine promotes invasive migration and
metastasis in the later stages of tumorigenesis (Micalizzi et. al., 2009; Xu H et. al., 2014;
Xu H et. al., 2015). We have previously shown that SIX1 modulates TGF-beta signaling
by decreasing canonical (Smad-mediated) responses and increasing non-canonical TGFbeta signaling pathways in HKc/HPV16 and HKc/DR cell lines (Xu H et. al., 2014; Xu
H et. al., 2015). Therefore, we analyzed signaling pathways in response to SIX1
knockdown in HKc/DR and observed alterations in the TGF-β pathway, including
diminished expression of EGFR and its associated ligand TGF-α, CTGF and its
downstream signaling effector ETS1, as well as MMP1 and MMP9. Further, the loss of
SIX1 in HKc/DR results in enhanced expression of TβRI and a reduction in TβRII.
Taken all together, these findings further confirm that SIX1 plays a very important role
during progression of HPV16-transformed human keratinocytes- toward a malignant
phenotype.
The effects of SIX1 knockdown, taken all together, corroborated and confirmed
our prior observations made on the same cells, HKc/DR (and HKc/HPV16) in which we
overexpressed SIX1, with major effects noted on pathways of EMT/MET, mainly
through TGF-β signaling (Xu H et. al., 2014; Xu H et. al., 2015). The central EMT
modulator, TGF-β, has a dual role in tumor development as well as in our cell lines
where it switches from growth suppressive to EMT-inducing in the progression of HPV-
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mediated transformation of human keratinocytes (Kowli et. al., 2013; Xu H et. al., 2014;
Xu H et. al., 2015).
TGF-β signaling is a critical pathway in which SIX1 overexpression promotes
EMT in HKc/DR cells. TGF-β receptors type I (TβRI), II (TβRII), and III (TβRIII) are
part of the TGF-β pathway cascade. Microarray data revealed a 1.57-fold increase in
TβRI and a 1.84-fold decrease in TβRII in HKc/DR in which SIX1 expression was
downregulated by our siRNA approach. Real-time PCR demonstrated similar results
with an approximate 70% increase in TβRI mRNA levels and a 30% decrease in TβRII
mRNA levels. This may indicate that a decline in SIX1 expression permits HKc/DR
cells transition from a differentiation resistant phenotype, with mesenchymal features,
towards a phenotype associated more closely with epithelial cells such as the
representation of TGF-β as a growth suppressive cytokine. The changes in the
expression of genes targeted by TGF-β are consistent with our interpretation that a shift
in TGF-β signaling from non-canonical to canonical, the opposite of what we detected
with SIX1 overexpression, occurs as a consequence of SIX1 loss.
As we have previously demonstrated, this shift is pivotal to produce the DR
phenotype and to further promote tumorigenicity in HPV-transformed cells (Xu H et. al.,
2014; Xu H et. al., 2015). Based upon our previous body of work elucidating the
mechanisms of TGF-β control of transcription from the HPV16 URR, we postulate that
the “shift” in TGF-β signaling from non-canonical to canonical, which we observed as a
consequence of inhibition of SIX1 expression, may be at the basis of the decrease in
E6/E7 expression. However, the specific mechanisms by which SIX1 and E6/E7 regulate
each other remain to be fully elucidated.
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The decrease in EGFR expression is also of considerable interest. While we can
explain it as a consequence of decreased E6 levels and increasing p53 levels, this
observation not only corroborates our overall interpretation of an interplay between
E6/E7 and SIX1 and a pivotal role of SIX1 in HPV16-mediated transformation and
tumor progression (Bheda et. al., 2008). EGFR loss has important functional
consequences, as malignant cells are known to escape suspension-induced cell death
(anoikis) through the increase of EGFR (Woappi et. al., 2017).
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CHAPTER 3
SIX1 OVEREXPRESSION EXTENDS THE LIFESPAN OF NORMAL
HUMAN KERATINOCYTES AND PROMOTES EPITHELIALMESENCHYMAL TRANSITION

3.1 INTRODUCTION
Sine oculis homeobox homolog 1 (SIX1) is a homeodomain-containing
transcription factor that has a critical role in the expansion of progenitor cells during
embryogenesis (Coletta et. al., 2008). SIX1 promotes tumor progression by induction of
epithelial-mesenchymal transition (EMT). SIX1 overexpression has been found in
various human cancers, including those of the breast, ovary, cervix and liver (AbateShen, 2002; Kumar JP, 2009). In HPV16-transformed human keratinocytes (HKc), SIX1
overexpression produces EMT and a differentiation-resistant phenotype at early stages of
in-vitro progression, and transforms cells to malignancy at late stages (Xu H et. al., 2014;
Xu H et. al., 2015).
Many studies have shown that inappropriate expression of embryonic genes,
particularly homeodomain transcription factors, contributes to tumorigenesis and/-or
tumor progression (Abate-Shen, 2002). In fact, genes critical for normal development are
often exploited by neoplastic lesions. The homeobox gene SIX1 encodes an embryonic
transcription factor broadly expressed during development in different tissues and organs,
including muscle, the auditory system, olfactory system and kidney, where it plays a
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critical role (Coletta et. al., 2010). The overexpression of SIX1 in cancer cells is
associated with tumor progression and metastasis, and decreased survival, mirroring its
developmental roles (Behbakht et. al., 2007).
SIX1 overexpression in immortalized and nontumorigenic mammary epithelial
cells and in premalignant HPV16-transformed cells in our model system induces
malignant transformation, leading to tumor formation in nude mice (McCoy et. al.,
2009). SIX1 is overexpressed in 50% of primary mammary carcinomas and 90% of
metastatic lesions (Reichenberger et. al., 2005). Additionally, SIX1 overexpression in
human breast cancer cell lines induces EMT and metastasis (Kumar JP, 2009; McCoy et.
al., 2009). SIX1 overexpression correlates with increased tumor malignancy and lymph
node metastasis (Zheng et. al., 2010). Moreover, SIX1 overexpression is significantly
associated with poorer overall survival in advanced-stage colorectal cancer (CRC) (Ono
et. al., 2012).
The overexpression of SIX1 has been extensively studied in cancer and cancerderived cells. In fact, SIX1 overexpression has been shown in immortalized mammary
epithelial cells to induce malignant transformation, leading to aggressive and invasive
tumors when injected into nude mice (Coletta et. al, 208). Furthermore, McCoy E. L. et.
al., 2009 have generated a transgenic mouse model that expresses the human SIX1 gene
in the mouse mammary epithelium. SIX1 expression in these non-transformed mammary
glands of mice induces tumors and increases the mammary stem cell population.
However, the ability of SIX1 to initiate malignant transformation in normal primary
human cells have yet to be investigate. Hence, we set out to investigate the biological
consequences of SIX1 overexpression, in-vitro, in primary normal HKc.

48

The focus of the present study was to explore the functional consequences of
SIX1 overexpression, alone or in combination with the overexpression of HRas-V12 and
an anti-p53 shRNA, in normal HKc. HKc/SIX1 and HKc/ALL3 grew continuously past
the end of the normal HKc lifespan and exhibited a spindle-shape and fibroblastic
appearance, rather than the cuboidal morphology of epithelial cells. Moreover, the growth
rates of HKc/SIX1 and HKc/ALL3 were comparable to those of early-stage HPV16immortalized HKc (HKc/HPV16). The invasiveness of HKc/SIX1 was comparable to
that of HKc/HPV16 and the invasiveness of HKc/ALL3 is greater than HKc/DR. Finally,
using microarrays, we demonstrated that SIX1 overexpression induces EMT in normal
keratinocytes. Overall, our data demonstrate that SIX1 facilitates the establishment of
primary human keratinocytes into cell lines with an extended lifespan, or perhaps into
stem-like cells, and induces epithelial-mesenchymal transition.

3.2 MATERIALS AND METHODS
Cell culture and treatment
The cell lines, HKc/HPV16-d1 and HKc/DRd-1, discussed in this work have been
previously described (Pirisi et. al., 1987; Pirisi et. al., 1988). Normal HKc were
maintained in keratinocyte serum-free medium supplemented with epidermal growth
factor (EGF) and bovine pituitary extract, BPE (KSFM, Invitrogen, Carlsbad, CA). HFb
were cultured in Dulbecco’s modified eagle’s medium containing 4500 mg/L glucose, Lglutamine, sodium pyruvate and sodium bicarbonate (DMEM, Invitrogen). HKc/HPV16-
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d1, HKc/DRd-1 and normal HKc cells were maintained in a humidified atmosphere of
5% CO2 at 37 oC. HFb was maintained in a humidified atmosphere of 10% CO2 at 37 oC.
Plasmid constructs and stable transfection
First or second passage normal HKc and HFb at 70% confluency were transfected
with either a pcDNA3.1/Zeo plasmid encoding human-SIX1 or a combination of three
plasmids: pcDNA3.1/Zeo-SIX1, a pBABE/puro plasmid encoding HRas-V12 and a
pSUPER/puro plasmid encoding a p53 shRNA. For transfection efficiency, the
pSUPER/puro plasmid encoding the GFP reporter gene was used. As a vector control, the
pSUPER/puro plasmid was used. Normal HKc and HFb were transfected with
Lipofectamine 3000 (Invitrogen) following the manufacturer’s instructions. Stable
transfectants, HKc/SIX1, HKc/ALL3, HFb/SIX1 and HFb/ALL3, were selected in
50 ug/mL Zeocin (Invitrogen) and/or 3 ug/mL Puromycin (Toku-E).
RNA interference (RNAi)
HKc were transfected with two different anti-SIX1 siRNA or anti-GFP siRNA
(control) duplexes using Lipofectamine RNAiMAX (Invitrogen) following the
manufacturer’s instructions. The protocol for transient transfections have been previously
described (Chapter 1).
Real-time PCR
Total RNA was isolated from cells using the RNeasy Plus Micro Kit (Qiagen,
Hilden, Germany). Reverse transcription was carried out with 1 μg of total RNA using
iScript cDNA Synthesis Kit (Bio-Rad, Hercules, CA). Real-time PCR was performed
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using iQ SYBR Green Supermix (Bio-Rad). All procedures were followed according to
the manufacturer’s instructions. The sequences of the primers used for real-time PCR
have been previously listed (Chapter 1, Table 2.1). GAPDH was used as an internal
control. All samples were assayed in duplicates.
Droplet digital PCR (ddPCR) for HRas-V12 mutation detection
Genomic DNA (gDNA) was isolated from cells using the AllPrep DNA/RNA
mini kit (Qiagen). Detection, amplification and quantitation of HRas-V12 was performed
by ddPCR, using the QX200 system (Bio-Rad) and probe-based assays (HRas p. G12V
and HRas WT for p. G12V PrimePCR ddPCR Mutation Detection Assays; Bio-Rad and
custom designed). All procedures were performed according to the manufacturer’s
instructions. The PCR mixture contained 12.5 μl of ddPCR droplet supermix for probes
(no dUTPs), 1.25 μl of mutation primer/probe mix (FAM), 1.25 μl of wild type
primer/probe mix (HEX) and 5 μl of gDNA (digested with MseI and diluted 1:10) in a
final volume of 25 μl. Twenty-five microliters of this mixture and 70 μl of droplet
generation oil were transferred to different wells of a droplet generation cartridge. After
formation of droplets using the droplet generator, samples were transferred to a 96-well
PCR plate. Plates were sealed at 180 °C using pierceable foil heat seal and a PX1 PCR
plate sealer (Bio-Rad). Samples were subjected to PCR amplification for 40 cycles at
94°C for 30 secs and 55°C for 60 secs. Droplets were analyzed on the droplet reader, and
Quantasoft software (version 1.4.0.99) was used for analyzing DNA concentrations.
Threshold lines for each primer/probe mix, which divides the positive and negative
droplets unequivocally, were determined and applied equally to all the samples.
Experiments contained control samples, such as wild type gDNA, mutant HRas-V12
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plasmid and no template. All samples were assayed in duplicates with at least three
biological replicates.
Enzyme-linked immunosorbent assay (ELISA)
Protein was isolated from cells using 10x Cell Lysis Buffer (Cell Signaling,
Danvers, MA). The extracted supernatant included a protease inhibitor (Sigma, Saint
Louis, MO). PathScan Total p53 Sandwich kit and PathScan Total Rb Sandwich kit were
used. Test procedure utilizing total protein was performed according to the
manufacturer’s instructions. 50 ug/ml of protein was loaded into the p53 pre-coated
wells. 150 ug/ml of protein was loaded into the Rb pre-coated wells. All samples were
assayed in replicates of two or three. Absorbance was read at 450 nm within 30 minutes
using a microplate reader.
Cell proliferation assay
The growth rates of HKc, HKc/SIX1, HKc/ALL3, HKc/HPV16-d1 and
HKc/DRd-1 were compared. Proliferation, at 24-hour intervals, was determined at
different passage numbers through the Cell Counting Kit-8 (CCK8) sensitive colorimetric
assay utilizing the WST-8 dye reagent (Dojindo, Rockville, MD). 5,000 cells in 500 ul of
their respective media were plated per well in 24-well plates. Cells were plated in
triplicate wells and 50 ul of WST-8 dye solution was added to each well and placed in a
CO2 incubator for 2 hours for reaction to take place. Absorbance was read at 450 nm
with a microplate reader.
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Cell invasion assay
The invasive ability of HKc/SIX1 or HKc/ALL3 in comparison with HKc,
HKc/HPV16-d1 and HKc/DRd-1 was measured using CultreCoat Basement Membrane
Extract (BME)-Coated Cell Invasion assay (Trevigen, Gaithersburg, MD). Boyden
chambers (24-well inserts) with an 8.0 μm polycarbonate (PC) membrane were used.
The top side of the membranes was coated with laminin I, collagen IV, entactin and
heparin sulfate proteoglycan. The upper surface of the matrix was challenged with
100,000 cells in complete medium. The lower chamber contained DR medium. After 24
hours, a mixture of Cell Dissociation Solution/Calcein AM was added to the bottom
chamber of each well and incubated for 1 hour. The number of invading cells was
quantified at 485 nm excitation, 520 nm emission with a microplate reader. Each
experiment was performed in triplicate wells.
Wound-healing assay
To compare the migration of HKc, HKc/SIX1, HKc/ALL3, HKc/HPV16-d1 and
HKc/DRd-1, cells were seeded into 60-mm plates and cultured until near confluency.
Then, the cell monolayer was scraped with a 200-uL pipette tip through the central axis
of the plate to generate artificial wounds. The wound distances were measured at 0, 4, 8,
12 and 24 hours under the microscope at 40X magnification. Images were captured in at
least five different fields. The experiments were performed in triplicates.
Clonogenic assay
To compare the ability of a single cell to grow into a colony 50,000 cells of HKc,
HKc/SIX1 and HKc/ALL3 were seeded onto 100-mm2 plates and cultured for 10 days.
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They were then washed twice with PBS, fixed in methyl acetate for 10 minutes and
stained with 10% Giemsa (Thermo Fisher Scientific, Waltham, MA) to evaluate colony
size. Experiments were performed in triplicate, and colonies with at least 50 cells
(cells ≥ 1 mm in diameter) were enumerated by ImageJ software (NIH, Washington,
D.C.) and compared between the different groups.
Population doubling (PD) and total cell output
To compare the replicative capacity between HKc and HKc/SIX1 or HKc/ALL3,
50,000 cells were seeded onto 100-mm2 plates and cultured for 10 days. Cells were
passaged and re-plated every 10 days up to 40 days. Experiments were performed in
triplicate and generation time was calculated with the following equation:
duration * log (2)
---------------------------------------------------------------------Log (Final concentration) – Log (Initial concentration)

The same dataset was utilized to calculate the total cellular output of cells
between HKc and HKc/SIX1 or HKc/ALL3. In general, the average number of cells after
each time point (every 10 days) was subtracted from the initial number of seeded cells
(5x104). Experiments were performed in triplicate.
Sphere-formation assay
To determine whether HKc/SIX1 and HKc/ALL3 exhibit anchorageindependence, spheroid-forming ability was tested. 96-well plates were coated with
100 ul of soft polymerized 0.5% agar in complete medium. 50-100 ul of cells
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(1 x 106 cells/ml) were suspended as a single-cell suspension. After 24 hours, spheroids
were photographed on a Nikon TMS phase microscope using Infinity 1 Analyze
software. Each experiment was repeated in replicates of two or three.
Gene-expression microarray analysis and validation by SYBR green real-time PCR
To correlate the genes and pathways that are affected in comparison with those
that are affected when SIX1 is suppressed in HKc/DR cells, we utilized the gene
expression array analysis from our previous study (Chapter 1).
Statistical analysis
Results were expressed as the mean ± standard deviation (SD). Data were
interpreted using student’s t-test. P ≤ 0.05, P ≤ 0.01 or P ≤ 0.001 were considered
statistically significant and indicated in the figures by *, ** or ***, respectively.

3.3 RESULTS
3.3.1 OVEREXPRESSION OF SIX1 IN NORMAL HKc
To investigate the behavior of SIX1 in normal HKc, we set out to explore the
effects of stably overexpressing SIX1 alone or in combination with HRas-V12 and p53i.
Normal HKc and normal HFb were transfected with either a pcDNA3.1/Zeo plasmid
encoding human-SIX1 or a combination of three plasmids: pcDNA3.1/Zeo-SIX1, a
pBABE/puro plasmid encoding HRas-V12 and a pSUPER/puro plasmid encoding a p53
shRNA that we had previously demonstrated to be specific and selective (Bheda et. al.,
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2008). Transfection efficiency was monitored with the co-transfection of the
pSUPER/puro plasmid (3:1 w/v), expressing GFP (Figure 3.1, A). Real-time PCR
confirmed that the mRNA levels of SIX1 were overexpressed in normal HKc (Figure 3.1,
B). SIX1 mRNA levels in HKc/SIX1 were comparable to HKc/DR cells while the
HKc/ALL3 cells were approximately 2.3-fold greater than the HKc/DR line. To compare
mutant-to-wild type allele ratio of ras, primer/probe sets specific for each allele were
utilized in ddPCR. The specificity of these primer/probe sets was shown with
pBABE/puro. HRas-V12 plasmid as the positive control (Figure 3.2, A). Utilizing
ddPCR, Ras-V12 to wild type ras ratios from equimolar amounts of genomic DNA
of HKc, HKc/ALL3, HKc/HPV16 and HKc/DR were detected. Ras-V12 was observed in
HKc/ALL3 and HKc/DR compared to HKc/HPV16 and HKc, which served as the
negative control (Figure 3.2, B).

A

B

Figure 3.1 The expression of SIX1 significantly increases in normal HKc transfected with
a SIX1 expression vector. (A) Representative image of successfully transfected cells.
Normal HKc transfected with pcDNA3.1/Zeo-SIX1; a combination of pcDNA3.1/ZeoSIX1pBABE/puro HRas-V12 and pSUPER/puro-p53 shRNA; or pSUPER/puro vector
control plasmid, and co-transfected with GFP (3:1 w/w) to monitor transfection
efficiency. GFP expression was analyzed 24-48 hours post-transfection at 200X
magnification. (B) Real-time PCR analysis for SIX1 mRNA in normal HKc transfected
with the SIX1 expression vector. SIX1 expression was normalized to GAPDH.
.
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B

Figure 3.2 The expression levels of HRas-V12 in HKc/SIX1 and HKc/ALL3.
(A) Experimental validation.1D-Dot plot. The blue histogram indicates the number of
droplets considered as positive for mutant Hras-V12 according to the fluorescence
threshold. The green histogram corresponds to the number of wild-type droplets. Mutant
control, DNA containing a 1:1 mix of mutant and wild type Hras-V12. WT control, DNA
containing only KRAS wild-type. Blank, water, no template control. (B) Detection
threshold of Hras-V12 from gDNA using ddPCR. 2D-Dot plot. Fluorescence results are
plotted as two-dimensional dot plots (similar to the depiction of flow cytometry data).
The region of these plots can be sequentially separated based on the fluorescence
intensity of each droplet. Grey dots correspond to empty droplets. Green dots correspond
to droplets containing wild-type copies of Hras. Blue dots correspond to droplets
containing Hras-V12 mutation. Each analysis was performed in duplicate. Experiments
were repeated at least three times. Nhkc contains no trace of mutant Hras-V12.
HKc/ALL3 cells were transfected with the mutant Hras-V12 DNA.
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Additionally, HKc and HFb cells transfected with the plasmids encoding SIX1,
HRas-V12 and p53i were tested for contamination with the HPV16-E6 and E7 viral
oncogenes. HKc/SIX1, HKc/ALL3, HFb/SIX1 and HFb/ALL3 were shown to not be
contaminated with HPV DNA (results not shown).

3.3.2 SIX1 DOWNREGULATES p53 IN HKc/SIX1
Once we confirmed the robust SIX1 expression in SIX1-transfected HKc, we next
explored the levels of the tumor suppressor genes p53 and Rb. p53 mRNA expression
levels were decreased by more than 70% in both HKc/SIX1 and HKc/ALL3 cells (Figure
3.3, A). The levels of p53 were significantly smaller than those in the HKc/HPV16 and
HKc/DR cell lines. p53 protein expression levels in HKc/SIX1 and HKc/ALL3 were
decreased approximately 60% in comparison to HKc and their protein levels were smaller
in comparison to the HKc/HPV16 and HKc/DR cell lines (Figure 3.3, B).
We next examined Rb mRNA levels in our transfected cell lines. Rb mRNA
expression was significantly increased in HKc/SIX1 and HKc/ALL3 (Figure 3.3, C).
There was a slight decrease in Rb protein levels in HKc/SIX1 with a slight increase in
HKc/ALL3 (Figure 3.3, D). Similarly, we have previously demonstrated that the
simultaneous knockdown of p53 and Rb in HKc results in the increase of SIX1 mRNA
expression levels, as well as in our HKc/HPV16 cell lines (Chapter 1, Figure 2.4).
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Given that SIX1 modulates p53 and Rb mRNA expression levels, we set out to
assess levels of p53 and Rb after the transient knockdown of SIX1 in HKc. We
demonstrated a significant reduction in p53 and Rb mRNA levels with a concomitant
reduction in respective protein levels, in cells treated with anti-SIX1 siRNA (Figure 3.4).
Collectively, we conclude that SIX1 regulates the expression of the p53 and Rb tumor
suppressor genes. Pathways that are affected in response to the expression of the SIX1
oncoprotein warrant further investigation.

A

B

C

D

Figure 3.3 The expression levels of p53 and Rb in HKc/SIX1 and HKc/ALL3. (A) Realtime PCR analysis of p53 mRNA in normal HKc. p53 expression was normalized to
GAPDH. (B) ELISA for p53 protein expression in normal HKc. (C) Real-time PCR
analysis of Rb mRNA in normal HKc. Rb expression was normalized to GAPDH. (D)
The relative protein expression of Rb in normal HKc. ELISA for Rb protein expression in
normal HKc.
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Figure 3.4 The expression of p53 and Rb decrease in normal HKc transfected with
pre-formed anti-SIX1 siRNAs. Real-time PCR analysis for SIX1, p53 and Rb mRNA in
SIX1-expressing HKc. Levels of expression were normalized to GAPDH; ELISA for p53
and Rb protein expression in SIX1-expressing HKc.
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3.3.3 HKc/SIX1 AND HKc/ALL3 DISPLAY AN EXTENDED LIFESPAN AND
RESISTANCE TO SERUM AND CALCIUM-INDUCED DIFFERENTIATION
A distinct feature of SIX1 overexpression in normal HKc was the continuous
growth of HKc/SIX1 and HKc/ALL3. pSUPER vector-transfected controls senesced.
Continuous growth past the end of the normal lifespan was also observed in HFb/SIX1
and HFb/ALL3. We have previously demonstrated that normal HKc and HKc/HPV16
can be cultured in conditions containing serum-free media and low Ca2+, whereas media
containing high-calcium or serum elicits terminal differentiation (Pirisi et. al., 1988; Xu
H et. al., 2015). One of the features of HKc/DR is resistance to serum and calciuminduced differentiation (Xu H et. al., 2015). We investigated whether the expression of
exogenous SIX1 in HKc/SIX1 and HKc/ALL3 induces differentiation resistance. Both
HKc/SIX1 and HKc/ALL3 grew well in media supplemented with either 5% or 10% fetal
bovine serum (FBS) and 1mM CaCl2 while HKc/DR grow best in similar media
containing 5% FBS. The results indicate that SIX1 generates differentiation resistance in
cells. In addition, HKc/SIX1 and HKc/ALL3 exhibited a spindle-shaped and fibroblastic
appearance (Figure 3.5, A). However, these epithelial cells remain morphologically
distinct from SIX1-overexpressing normal HFb (Figure 3.5, B). The extended lifespan of
HKc/SIX1 and HKc/ALL3 ultimately ended with senescence by passage 30, with or
without the supplementation of serum and calcium. These data suggest that SIX1
prolongs the lifespan of epithelial cells but is not, by itself, capable of inducing
immortalization.
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A

Figure 3.5 Morphological changes due to SIX1 overexpression in normal HKc and HFb.
(A) Cell morphology of normal HKc, HKc/SIX1 and HKc/ALL3. Images are shown at
200X magnification. (B) SIX1 overexpression in normal HFb. Cell morphology of
normal HFb, HFb/SIX1 and HFb/ALL3. Images are shown at 200X magnification.

3.3.4 SIX1-EXPRESSING CELLS ARE CULTURED FROM KERATINOCYTES AND
EXHIBIT EPITHELIAL FEATURES, DESPITE THEIR FIBROBLASTIC
MORPHOLOGY
During the beginning stages of foreskin processing, a necessary step is the
separation of the dermis from the epidermis. To verify that the SIX1-expressing epithelial
cells were of keratinocyte origin, we compared mRNA levels of E-cadherin, Fibronectin,
N-cadherin, SNAIL, TWIST and Vimentin (VIM) with that of non-transfected HFb. We
also analyzed expression levels of Keratin 14 (K14), an epidermal gene, as well as
Keratin 19 (K19), a transformation marker. There were nominal levels of E-cadherin in
HKc/SIX1 and HKc/ALL3, possibly due to their ongoing epithelial to mesenchymal
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transition. There were significant expression of the mesenchymal markers Fibronectin
and N-cadherin but their mRNA levels were smaller in comparison to HFb (Figure 3.6).
HKc/SIX1 and HKc/ALL3 seem to demonstrate an intermediate “metastable” state of
EMT. There was a significant increase in TWIST but not in SNAIL for the HKc/SIX1
and HKc/ALL3 cells. Moreover, there was a significant increase in the mesenchymal
marker VIM in the HKc/SIX1 cells. HKc/SIX1 seems to demonstrate a more advanced
metastable stage of EMT in comparison to HKc/ALL3. Lastly, mRNA expression levels
of K14 were nominal in the SIX1-expressing cells, perhaps due to EMT, and K19 levels
were depicted to be significant, possibly demonstrating that these cells are undergoing
transformation.
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Figure 3.6 Expression of epithelial and mesenchymal-associated genes in SIX1expressing normal cells. The levels of mRNA expression of E-cadherin, Fibronectin, Ncadherin, TWIST, SNAIL, VIM, K14 and K19 were determined by real-time PCR
analysis in normal HKc, normal HFb, HKc/SIX1 and HKc/ALL3. Data were normalized
to GAPDH expression.

3.3.5 INCREASE IN SIX1 INDUCES ALTERATIONS IN GROWTH, INVASION
AND MIGRATION IN HKc/SIX1 AND HKc/ALL3
To further elucidate the functional role of SIX1 in HKc, we proceeded to
demonstrate their proliferative capacity and invasive ability. The growth rates of
HKc/SIX1 and HKc/ALL3 were comparable to the HKc/HPV16 cells (Figure 3.7, A).
We also demonstrated that as the passage number increased, the proliferative capacity of
HKc/SIX1 and HKc/ALL3 increased. Moreover, invasion assays demonstrated that
HKc/SIX1 is more invasive than normal HKc, and their invasiveness is comparable to
that of HKc/HPV16. The invasiveness of HKc/ALL3 is greater than the HKc/DR cells,
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which are about 2.5-fold more invasive than HKc/HPV16 (Figure 3.7, B). Additionally,
we demonstrated that as the passage number increased, the invasive abilities of our SIX1expressing cell lines increased as well.
Given that the SIX1-expressing cells presented an enhanced rate of proliferation
and invasion, we set out to explore their migratory potential by utilizing a wound-scratch
assay. Furthermore, HKc/SIX1 and HKc/ALL3 restored 77% and 79%, respectively, of
the wounded area within 24 hours in culture (Figure 3.7 C, D). Their rate of wound
closure fell in-between that of HKc/HPV16 and HKc/DR (Table 3.1). These results
further validate that HKc/SIX1 and HKc/ALL3 exhibit a mesenchymal phenotype and
demonstrate their increases in cell proliferation, invasion and migration in comparison to
HKc.

A
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Figure 3.7 SIX1 overexpression induces alterations in growth, invasion and migration in
normal HKc. (A) Cell proliferation was determined by the Cell Counting Kit-8 (CCK8)
colorimetric assay utilizing the WST-8 dye reagent at the days indicated in normal HKc,
HKc/SIX1, HKc/ALL3, HKc/HPV16 and HKc/DR. (B) Invasion assays for normal
HKc, HKc/SIX1, HKc/ALL3, HKc/HPV16 and HKc/DR. Basement membrane extract
(BME) cell invasion as determined by transwell migration. Quantification of invading
cells was determined by the addition of calcein AM after 24 hours. (C) Percentage of
wound closure after a scratch in normal HKc, HKc/SIX1, HKc/ALL3, HKc/HPV16 and
HKc/DR at the time points indicated. (D) Scratch-wound assay depicting the migratory
behaviors of normal HKc, HKc/SIX1, HKc/ALL3, HKc/HPV16 and HKc/DR at 12-hour
intervals.
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Table 3.1 Percentage of wound closure between NHKc, HKc/SIX1, HKc/ALL3,
HKc/HPV16 and HKc/DR.

3.3.6 SIX1-EXPRESSING EPITHELIAL CELLS DISPLAY HIGH CLONAL
GROWTH AND INCREASED REPLICATIVE CAPABILITY
To assess the ability of HKc to form colonies, 5x104 cells were plated in 100-mm2
dishes and sub-cultured for 10 days. Normal HKc were used as controls. HKc/SIX1 and
HKc/ALL3 demonstrated more robust colony formation, more than 3-fold, in comparison
to HKc (Figure 3.8, A; Table 3.2). Additionally, HKc/SIX1 and HKc/ALL3 both
underwent nearly 24 population doublings (PD) within 40 days in culture, compared to
the 9 PD acquired by HKc (Figure 3.8, B; Tables 3.3, 3.4). The approximate doubling
time of HKc/SIX1 and HKc/ALL3 was between 48-60 hours in comparison to the
doubling time of 72 hours in normal HKc. Lastly, the total concentration of cells in
HKc/SIX1 and HKc/ALL3 were up to 14- and 16- fold greater, respectively, than normal
HKc after 30 days in culture (Figure 3.8, C; Table 3.5). These findings suggest that SIX1expressing epithelial cells have the increased capacity to replicate and produce a
significant number of colonies within a shorter period.
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Figure 3.8 HKc/SIX1 and HKc/ALL3 display high colony density and increased
replicative capability. (A) 5x104 cells were plated in 100-mm2 dishes, sub-cultured and
colony patterns were examined by Giemsa staining after 10 days. Normal HKc,
HKc/SIX1 and HKc/ALL3 after 10 days in culture. (B) Cumulative population doublings
(PD) observed in HKc/SIX1 and HKc/ALL3 relative to normal HKc over the course of
40 days. (C) Total cell output in HKc/SIX1 and HKc/ALL3 relative to normal HKc over
the course of 40 days.

69

Table 3.2 Clonal growth of NHKc, HKc/SIX1 and HKc/ALL3 10 days in culture.
Significant increase in dish occupancy of HKc/SIX1 and HKc/ALL3 relative to normal
HKc after 10 days in culture. Cells were manually counted and quantified by ImageJ
software to determine colony density 10 days after being in culture.

Table 3.3 Cumulative population doublings NHKc, HKc/SIX1 and HKc/ALL3.

Table 3.4 Estimated doubling times of NHKc, HKc/SIX1 and HKc/ALL3.

Table 3.5 Total cell output between NHKc, HKc/SIX1 and HKc/ALL3 over the course of
40 days. Initial number of seeded cells was 5x104.
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3.3.7 HKc/SIX1 AND HKc/ALL3 SURVIVE IN SUSPENSION CULTURE
To understand whether HKc/SIX1 and HKc/ALL3 have the capability to evade
programmed cell death upon loss of adhesion to a monolayer culture substrate, we
utilized a spheroid culture model containing a mixture of agarose and KSFM to
investigate their spheroid forming abilities. HKc/SIX1 and HKc/ALL3 had the capability
to aggregate into multicellular spheroids (Figure 3.9 A, B). Furthermore, when the
suspended spheroids were transferred from the spheroid culture back to a monolayer
culture, they readily adhered and began proliferating (Figure 3.9 C-F). These findings not
only demonstrate that SIX1-expressing keratinocytes can overcome suspension-induced
cell death (anoikis), accumulate and assemble into spheroids in a suspension culture, they
remain functionally viable (up to at least eight passages) once re-plated from the spheroid
culture back into a monolayer culture (Woappi Y et. al., 2017). In addition, spheroidderived HKc/SIX1 and HKc/ALL3 returned to a cobblestone-type morphology when replated in monolayers.
3.3.8 SIX1 OVEREXPRESSION IN NORMAL HKc PROMOTES EMT
Due to the changes in cellular morphology and behavior, such as growth and
invasion, in HKc/SIX1 and HKc/ALL3, we set out to investigate the expression of EMT
related genes. This study explored the effects of SIX1 overexpression in normal HKc on
global gene expression through the utilization of Affymetrix GeneChip Human Gene 2.0
ST Arrays. We used Transcriptome Analysis Console (TAC) software from Affymetrix
to analyze the microarray results. We were interested in the same set of genes as our
paper (Chapter 1) that discussed the role of SIX1 knockdown on global gene expression
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in HKc/DR cell lines. To determine the differentially expressed genes from the
microarray dataset, we used a fold change >1.4 (up and down) and a P value > 0.01 as
cutoff values.

A
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F

Figure 3.9 HKc/SIX1 and HKc/ALL3 survive in suspension culture. (A) HKc/SIX1 in
spheroid (B) HKc/ALL3 in spheroid (C) (D) HKc/SIX1 at eight passages after
suspension culture. 40X and 100X, respectively. (E) (F) HKc/ALL3 at 24 hours after
suspension culture. 40X and 100X, respectively. Data not shown for eight passages after
suspension culture.

B
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The following images (Figure 3.10; Tables 3.6, 3.7) demonstrate the differentially
expressed genes that were either upregulated or downregulated in HKc/SIX1 and
HKc/ALL3. Based on our microarray data from our original paper (Chapter 1), we
analyzed the following set of genes, which included EMT-associated genes regulated by
TGF-β (Wendt et. al., 2009): connective tissue growth factor (CTGF/CCN2),
β-catenin (CTNNβ1), ETS proto-oncogene 1, transcription factor (ETS1), Keratin-15
(K15), Occludin (OCLN) and TGF-β receptors type I and II (TβRI, TβRII). We also
investigated the epidermal proliferation gene, ki-67, and epidermal growth factor
receptor, EGFR. To validate the array data, we performed real-time PCR. In the
HKc/SIX1 and HKc/ALL3 cells, we observed an increase in the angiogenic matricellular
marker CTGF and a reduction in its downstream signaling effector ETS1 (Ubink et. al.,
2016; Geisinger et. al., 2012). HKc/SIX1 displayed significant increases in expression of
the inflammatory response gene prostaglandin-endoperoxide synthase 2, PTGS2
(cyclooxygenase-2, COX-2). There were significant increases in peroxisome proliferator
activated receptor gamma (PPARγ), a ubiquitously expressed gene known to regulate
differentiation and cell growth (Sarraf et. al., 1999).
Additionally, there was a decrease in the expression of the cell-cell adhesion
complex molecule CTNNβ1 (Gumbiner et. al., 2005). As expected, we observed a
reduction in the expression of the epithelial-related genes K15 and OCLN. We noted an
increase in the pro-survival factor EGFR. Lastly, we noted an increase in ki-67 mRNA
level. These data suggest that a consequence of SIX1 is the activation of EMT in normal
HKc.

73

Table 3.6 Expression of EMT and MET-associated genes targeted by SIX1 and TGF-β in
normal HKc.

Table 3.7 Expression of EMT and MET-associated genes targeted by SIX1 and TGF-β in
normal HKc.
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Figure 3.10 SIX1 overexpression in normal HKc promotes EMT. Levels of mRNA
expression of CTGF, CTNNβ1, EGFR, ETS1, ki-67, K15, OCLN, PPARy and PTGS2
(COX-2) were determined by real-time PCR analysis in normal HKc, HKc/SIX1 and
HKc/ALL3. Data were normalized to GAPDH expression.
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3.3.9 INCREASE IN SIX1 EXPRESSION MODULATES TGF-β RECEPTOR mRNA
LEVELS IN NORMAL HKc
We attempted to identify pathways known to dictate SIX1-induced EMT within
the normal HKc population. TGF-β signaling is a critical pathway in which SIX1
overexpression promotes EMT in malignant cells. The central EMT modulator, TGF-β,
is known to exhibit a dual role in tumor development as well as in our HKc/HPV16 and
HKc/DR cell lines. TGF-β has been shown to switch from growth suppressive to EMTinducing in the progression of HPV-mediated transformation of human keratinocytes
(Wendt et. al., 2009). The majority of genes described here are known to be regulated by
TGF-β signaling. TGF-β receptors type I (TβRI), II (TβRII), and III (TβRIII) are part of
the TGF-β pathway cascade. Previous microarray data revealed an increase in TβRI and
a decrease in TβRII when SIX1 was decreased in the HKc/DR lines (Chapter 1). Realtime PCR demonstrated similar results. In contrast, when we tested TβRI and TβRII
mRNA expression levels in HKc/SIX1 and HKc/ALL3 we observed a decrease in TβRI
and an increase in TβRII (Figure 3.11), similar to what we have observed when we
increase SIX1 levels in our HKc/HPV16 and HKc/DR cell lines (Xu H et. al., 2014; Xu
H et. al., 2015).
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Figure 3.11 SIX1 modulates TGF-β receptor mRNA levels in normal HKc. Levels of
mRNA expression of TGFβRI and TGFβRII were determined by real-time PCR analysis
in normal HKc, HKc/SIX1 and HKc/ALL3. Data were normalized to GAPDH
expression.

3.4 DISCUSSION
It is well documented that the signaling pathways involved in carcinogenesis
often represent aberrations of molecular activities that occur during early development.
Misexpression of embryonic transcription factors are known to lead to carcinogenesis
(Abate-Shen et. al., 2002). These proteins reestablish developmental programs out of
context. SIX1 is a developmentally restricted transcription factor that inappropriately
reinstates numerous embryonic pathways, including growth, proliferation, survival and
migration during oncogenesis (Kumar et. al., 2009). Indeed, the SIX1 oncofetal protein
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participates in the regulation of numerous pediatric and adult cancers (Abate-Shen et. al.,
2002; Coletta et. al., 2010; Kumar et. al., 2009).
Serrano M. et. al., 1997 demonstrated that transformation of primary cells
by ras requires either an oncogene or the inactivation of tumor suppressors such as p53,
p21 or p16. Oncogenic ras induces senescence through p53 and p16 in primary human or
rodent cells; and therefore, inactivation of p53 and/-or p16 prevents ras-induced arrest in
these cell types that are not transformed nor immortalized (Serrano et. al., 1997). With
this in mind, we have shown that the overexpression of SIX1 extends the lifespan of
normal HKc and pushes these cells to become resistant to serum and calcium-induced
differentiation in culture. SIX1 expression in normal HKc induces a spindle-shaped and
fibroblastic appearance rather than the known cuboidal morphology of epithelial cells.
Moreover, HKc/SIX1 and HKc/ALL3 cells demonstrated increases in cell proliferation,
invasion and migration compared to HKc.
As a result of SIX1 expression in normal HKc, p53 mRNA and protein expression
levels were drastically decreased. SIX1 is not implicated to affect levels of p53 until
Towers et. al., 2015, discovered that SIX1 downregulates p53 through a mechanism that
involves the direct upregulation of microRNA-27a and the simultaneous downregulation
of the p53-translational regulator, ribosomal protein L26 (RPL26) (Towers et. al., 2015).
Similarly, we have shown that the simultaneous knockdown of p53 and Rb in HKc
results in the increase of SIX1 mRNA expression levels. Together, these findings
demonstrate that SIX1 has a relationship with p53 that warrants further investigation.
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The development of metastatic lesions has been known to contribute to the
dysregulation of oncogenes and tumor suppressor genes. Li et. al., 2013 have shown that
silencing of SIX1 decreased phosphorylation levels of Rb in human pancreatic carcinoma
cell lines (PANC-1). This may explain SIX1 induced hyperproliferation, cell growth and
cell cycle progression (Li Z et. al., 2013). Similarly, in normal HKc, we have shown that
overexpressing SIX1 leads to an increased expression of Rb. This tumor suppressor gene
is known to bind to E2F and inhibit transcriptional regulation by E2F and cell cycle
progression (Young et. al., 2003). SIX1 expression is known to be regulated by the E2F
family member E2F1. The overexpression of SIX1 leads to the deregulation of cell cycle
checkpoints including E2F (Kumar et. al., 2009). The mechanism for this action is
unknown in the HKc/SIX1 and HKc/ALL3 cell lines and needs further elucidation. We
hypothesize that E2F detaches from Rb during the upregulation of SIX1 that leads to cell
cycle progression and aberrant proliferation of SIX1-expressing cells. E2F can therefore
activate cell cycle genes, while allowing for the aberrant expression of the embryonic
gene SIX1. In turn, Rb mRNA levels rise to increase the production of Rb protein levels.
However, the rate of Rb protein production cannot be significantly increased in order to
attach to E2F and inhibit increased cell growth and cell cycle de-regulation (Kumar et.
al., 2009; Young et. al., 2003). Thus, the misexpression of SIX1 in normal or
tumorigenic cell lines leads to deregulation of cell-cycle checkpoints, promoting cellular
proliferation.
It has been shown that SIX1-expressing malignant cells display larger colony size
and higher colony formation rate in soft agar while evading anoikis. SIX1 has been
shown to promote tumor cell proliferation in-vitro and growth in-vivo (Liu et. al., 2014).
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In concordance with these findings, our experiments of colony formation, including in
soft agar, demonstrated that HKc/SIX1 and HKc/ALL3 produce robust colony formation
in monolayer, and survive in suspension, suggesting that SIX1-expressing epithelial cells
have the increased capacity to replicate and produce a significant number of colonies
within a shorter period.
The changes in cellular morphology and behavior, such as growth and invasion,
which were exhibited in HKc/SIX1 and HKc/ALL3 as a result of SIX1 overexpression,
lead us to investigate the expression of EMT related genes. Based on our published array
data from our previous work (Chapter 1), we analyzed the differential expression of
numerous genes. We validated, through real-time PCR, the increased expression of
CTGF and decreased expression of ETS1. Tumorigenic cells are known to metastasize
via blood or lymphatic vessels through an increase in CTGF/CCN2 (Ubink et. al., 2016).
Moreover, there was a decrease in the expression of CTNNβ1, in contrast to what we
observed in our HKc/DR cells that underwent a loss of SIX1. In this present context, this
could be attributed to a shift away from an epithelial phenotype with changes that follow
a loss in cell adherens junctions. We also observed a reduction in the expression of the
epithelial-related genes K15 and OCLN. We noted an increase in the pro-survival factor
EGFR. Malignant cells are known to escape anoikis through the increase of EGFR
(Woappi et. al., 2017). Lastly, we noted an increase in ki-67 mRNA level. These data
suggest that EMT is due to SIX1 overexpression in normal HKc. Therefore, a significant
increase in these markers parallels an EMT phenotype and is an indication of the
functional consequences brought on by an increase in SIX1.
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We have demonstrated that activation of TGF-β pathway is necessary to maintain
most of the epithelial plasticity from forced SIX1 expression. We have also shown that
SIX1 is a critical mediator of epithelial plasticity and TβRII induction through its ability
to induce TGF-β-dependent EMT. We demonstrate that SIX1 expression in HKc/SIX1
and HKc/ALL3 induces properties of oncogenic EMT. Further, we observed a decrease
in TβRI and an increase in TβRII in SIX1-expressing epithelial cells. This may indicate
that an increase in SIX1 expression permits normal HKc to begin their transition away
from an epithelial and towards a mesenchymal phenotype, as TGF-β switches from a
growth suppressive to a growth promoter cytokine.
Stem cells, which are found in normal tissue, have the ability of self-renewal
through cell division along with the generation of progenitor cells that will eventually
differentiate into cells and tissues of various functions. Many studies have also
determined that a small proportion of malignant cells and tissues have self-renewing,
stem cell like properties (Mani et. al., 2008). These cells have been termed cancer stem
cells (CSCs). CSCs have the ability to produce new tumors within the heterogeneous
malignant cell populations (Mani et. al., 2008). Along similar lines, activation of EMT in
immortalized cells produces many of the properties associated with stem cells, such as
self-renewal (Mani et. al., 2008). The process of EMT is known to mediate tumor
progression, metastasis and CSC properties (Christiansen et. al., 2006). Therefore, the
transient induction of EMT in our HKc/SIX1 and HKc/ALL3 cells may allow for the
possibility of generating stem cell like features.
In summary, SIX1 promotes hyperproliferation and invasiveness, indicative of
cellular transformation, in the background of normal HKc. SIX1 facilitates the
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establishment of primary human keratinocytes into cell lines with extended life span, or
perhaps into stem-like cells with extended proliferation potential. The mechanisms
underlying the pro-tumorigenic and pro-metastatic properties of SIX1 include the
activation of multiple signaling pathways. We have shown that SIX1 has the ability to
extend the lifespan of normal epithelial cells and induce an oncogenic EMT pathway
through the activation of TGF-β and its downstream targets.
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